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Abstract 
 
Activation and proliferation of cardiac fibroblasts are the prime mediators of cardiac 
fibrosis. Existing studies show that ROS and inflammatory cytokines produced during 
fibrosis not only signal proliferative stimuli but also contribute to DNA damage. 
Therefore, as a prerequisite to maintain sustained proliferation in fibroblasts, 
activation of distinct DNA repair mechanism is essential. We have previously shown a 
protective epigenetic role of TET3 in organ fibrosis. Here, we demonstrate that TET3 
additionally impacts DNA damage response (DDR) mechanisms via orchestrating 
checkpoint-assisted homologous recombination (HR)-mediated DDR, and that TGF-
ß, in combination with lack of TET3 in cardiac fibrosis, leads to an increase of a 
checkpoint-arrest independent non-homologous end joining (NHEJ) DDR.  Finally, 
we provide evidence that overexpression of TET3 reduces the increased proliferation 
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1. Introduction 
 
1.1 Cardiovascular diseases and cardiac fibrosis 
 
                    Cardiovascular disease is the leading cause of death worldwide. A recent 
statistic released by the WHO accounts an estimated 17.9 million deaths from CVDs, 
representing 48 % of the worldwide mortality (Mendis et al, 2011; WHO, 2018). 
Notably, almost all forms of CVDs are aggravated by and associated with cardiac 
fibrosis (Hinderer & Schenke-Layland, 2019). Cardiac fibrosis is a scarring process 
characterised by excessive accumulation of extracellular matrix (ECM) proteins that 
can lead to increased myocardial stiffness eventually resulting in impaired systolic and 
diastolic function in the heart (Ho et al, 2010; Rockey et al, 2015; Travers et al, 2016).  
 
ECM in the heart is primarily composed of collagen I (mostly confers strength) and 
collagen III (mostly confers elasticity) which predominantly provide the fundamental 
structural network to deliver strength and elasticity to the myocardium (Berk et al, 
2007; Kong et al, 2014). Besides providing strength and elasticity to the myocardium, 
ECM also serves as a homeostatic buffer for growth factors and cytokines, facilitating 
intracellular crosstalk within the myocyte and non-myocyte cells (Fan et al, 2012; Li et 
al, 2018). Increased accumulation of ECM during fibrotic progression causes enhanced 
stiffening of the heart muscles and impairs normal physiological systolic and diastolic 
functions in the organ (Kim et al, 2000). Therefore, a proper balance between the 
deposition and degradation of ECM is essential in healthy hearts.  
 
                       
Figure 1. Pie-chart showing overall mortality % (worldwide) in both men and women 




TET3 impacts cardiac fibrosis partially via regulation of DNA damage response 
  
Sandip Kumar Rath  2019  Page 3 
1.1.1 Types of cardiac fibrosis 
 
                    Fibrosis in the heart has been described to develop in two possible ways (a) 
reactive (b) reparative/replacement fibrosis (Brilla & Weber, 1992; Liu et al, 2017). 
Reparative fibrosis occurs in response to injury during myocardial infraction (Lopez et 
al, 2001). In myocardial infarction dead cells (mostly cardiomyocytes) accumulate due 
to untimely apoptosis or necrosis in the infarcted area, which are then removed and 
replaced by excessive deposition of non-myocyte cells to form a scar (Desmoulière et 
al, 1995; Piek et al, 2016). Excessive apoptosis and necrosis during chronic infarction 
release a lot of cytokines (such as TGF-β, IL-4 and IL-6) that in the end result in 
pathological fibrosis in the heart (Chiong et al, 2011; Greulich et al, 2019; Saraste et al, 
1997). Although such scarring process is initiated to preserve the structural integrity of 
the organ, excessive scarring due to chronic injury eventually leads to impaired cardiac 
function. 
 
In contrast to reparative fibrosis, reactive fibrosis mostly occurs in response to 
mechanical stress, pressure overload or due to changes in neuro-hormonal signalling 
cascade but acute cell loss is absent (Liu et al, 2017; Talman & Ruskoaho, 2016). 
Initiation of reparative fibrosis leads to excessive deposition of extracellular matrix 
proteins by activated fibroblasts without causing a significant loss of cardiomyocytes. 
 
                         
Figure 2. Schematic representation of replacement and repairment cardiac fibrosis. 
Adapted from Mewton et al. (Mewton et al, 2011). Copy right license number 4704831089992.       
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1.1.2 Cardiac Fibroblasts 
 
                    The heart as an organ is composed of two major cell types, cardiomyocytes 
and non-myocytes (Zhou & Pu, 2016). Fibroblasts belong to the non-myocytic 
population that plays a prime role in fibrogenesis (Humeres & Frangogiannis, 2019; 
Travers et al, 2016). During pathological remodelling, fibroblasts are activated and 
undergo transformation to activated fibroblasts (also known as myofibroblasts) (Kong 
et al, 2014). The activated fibroblast in turn secretes several cytokines, growth factors, 
reactive oxygen species, ECM proteins and matrix metalloproteinases that disrupt 
proper function of the heart (Chen & Frangogiannis, 2013; Shinde & Frangogiannis, 
2014). Cardiac fibroblasts are diffusely interspersed between cardiomyocytes and 
recent studies show they play a crucial role in transmission of electrical signals in the 
myocardium (Zhang et al, 2012). A recent in vitro study indicates that cardiac 
fibroblasts exchange electrical signals between cardiomyocytes via connexin 43, which 
helps in spontaneous synchronization of beating in distant cardiomyocytes. 
 
Although the actual number of fibroblast population in the heart is still not clear, it is 
estimated to comprise 11-15 % of the total cell population in the adult mouse heart and 
about 55-65 % in the adult rat heart (Zhou & Pu, 2016). Lineage tracing studies in 
pressure overload induced mouse models demonstrate that 15-20 % of the fibrotic 
fibroblasts in the ventricles are derived primarily by endothelial cells whereas the rest 
80-85% of the total fibrotic fibroblasts are derived from either epicardial cells or the 
resident fibroblasts (Kanisicak et al, 2016; Moore-Morris et al, 2014; Zeisberg et al, 
2007). Interestingly, the origin of cardiac fibroblasts in each species are quite distinct, 
hence its distribution of population in heart is extremely heterogeneous in nature 
(Zeisberg & Kalluri, 2010).  
                                                   
 
Figure 3. Schematic illustration showing the source of cardiac fibroblasts.  
Adapted and modified from Krenning et al. (Krenning et al, 2010). Copy right license number 
4704831415631. 
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1.1.3 The role of TGF-β in fibroblast activation  
 
              TGF-β is considered to be one of the critical cytokines released in the fibrotic 
heart that plays a central role in the activation and proliferation of cardiac fibroblasts 
(Khalil et al, 2017; Liu et al, 2017). Activated fibroblasts are also known as 
myofibroblasts whose primary role during fibrotic response is to secrete excessive 
extracellular matrix proteins, inflammatory cytokines and ROS that casually 
contributes to more damage in the myocardium (Humeres & Frangogiannis, 2019; 
Humeres et al, 2016). There are three isoforms of TGF-β in mammals, i.e. TGF-β1, 
TGF-β2 and TGF-β3, of which TGF-β1 is the most predominant (Wu et al, 2018). Three 
separate genes encode the three isoforms but all three genes share a high degree of 
homology (Frank et al, 1996). All the three isoforms are secreted as an inactive form 
and are activated after proteolytic cleavage (Shi et al, 2011). Once activated, TGF-β 
mediates its effect via binding to its receptors TβRI, (also known as ALK5) and TβRII 
resulting in phosphorylation of Smad2/3  (Hayashi & Sakai, 2012). Activated Smad2/3, 
in turn, binds to Smad4 resulting in translocation into the nucleus (Chen et al, 2005). 
Once the phosphorylated smad 2/3/4 complex enters the nucleus and binds to genomic 
DNA, it facilitates transcription of essential genes involved in fibrogenesis (Khalil et al, 
2017). Recent studies have shown that fibroblast-specific deletion of Tgfbr1/2 or 
Smad3, but not Smad2, results in an attenuated fibrotic response in a pressure 
overload-induced cardiac fibrosis model. This clearly signifies the importance of 
activated TGF-β signalling pathway in regulating the fibrotic progression (Khalil et al, 
2017).  Studies also demonstrate that independent of its smad mediated transcription 
activities, TGF-β can activate various signalling cascades like TGF-β-activated kinase 1 
(TAK1), extracellular signal regulated kinase (Erk), p38 Mitogen activated protein 
kinase (MAPK), c-Jun-N-terminal kinase (JNK), and GTPase pathways (Zhang, 2009). 
Previous studies show that transient activation of the RAS/MEK/ERK cascade by TGF-
β results in increased CTGF expression, actin stress fiber formation and ECM 
contraction (Chatzifrangkeskou et al, 2016). 
 
 




           
                   Studies since the last two decades have highlighted the critical role of 
epigenetics in deciphering the nature and cause of dynamic heterogeneous changes in 
gene expression profiles associated with unchanged DNA sequences (Nicoglou & 
Merlin, 2017). Ongoing studies have shown that epigenetic changes in heart during 
pathological disease state such as fibrosis can lead to invariant change in gene 
expression regulated either at DNA, histone or at transcriptome levels (Kmietczyk et 
al, 2019; Mathiyalagan et al, 2014; Tao et al, 2014). Interestingly, although epigenetic 
changes are heritable, they are also reversible in nature owing to the presence of 
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numerous epigenetic writers and erasers (Nicoglou & Merlin, 2017). Numerous 
emerging studies confirm the role of epigenetic factors in programming the activation 
and proliferation of cardiac fibroblasts during cardiac fibrosis (Felisbino & McKinsey, 
2018). A recent study in a pressure overload induced cardiac fibrosis model highlights 
the role of histone acetylation in regulating the expression of proliferative genes such 
as p15 and p57 to maintain a sustained proliferation of cardiac fibroblasts during 
fibrosis (Williams et al, 2014). Similarly, another study demonstrates the effect of 
inhibition of p300 histone acetyltransferase in blocking the proliferative response of 
cardiac fibroblasts during fibrogenesis. Evidence also highlight the role of DNA 
methylation in cardiac fibrosis (He et al, 2019; Olsen et al, 2017). A previous study by 
our group has demonstrated that increased hypermethylation of RASAL1 (a key anti-
fibrotic gene) leads to aggravation of fibrosis by enhancing the endothelial to 
mesenchymal transition, resulting in increased activated fibroblast deposition (Xu et 
al, 2015). In the same study it is reported that treatment of fibrotic hearts with BMP-7 
can attenuate the progression of cardiac fibrosis by erasing the methyl mark at the 
RASAL1 promoter through increased expression of DNA demethylase TET3. Another 
study in rat cardiac fibroblasts demonstrate that increased fibroblast activation is 
associated with decreased RASSF1a expression due to promoter methylation of the 
gene by DNMT1 (Tao et al, 2014). Moreover, the same study reports that fibroblast 
activation can be blocked by   expressing RASSF1a by treating with DNMT inhibitor 5-
aza-2′-deoxycytidine. All these studies strongly suggest the involvement of epigenetic 
signatures in regulating cardiac fibrosis. Altogether from the above studies, DNA 
methylation and demethylation are emerging as one of the key epigenetic modification 
that can be exploited therapeutically to restrain or even revert cardiac fibrosis.  
 
 
1.2.2 TET enzymes 
 
                   One of the breakthroughs in solving the riddle of active demethylation 
process came to light in early 2009 with the discovery of TET enzymes, best known for 
their ability to convert 5mC to 5hmC, 5fc and 5caC (Tahiliani et al, 2009). TET enzymes 
are called after the ten-eleven translocation (t (10;11) (q22; q23)), found in cases of 
patients suffering from acute myeloid and lymphocytic leukemia (Tahiliani et al, 
2009). Emerging studies have emphasized the role of TET proteins in diverse cellular 
processes like gene transcription, stem cell differentiation, immune cell maturation, 
embryonic development, proliferation, DDR and so on, making them a potential gene 
of interest in the field of development and diseases (Rasmussen & Helin, 2016; Tan & 
Shi, 2012). However, the molecular mechanism orchestrated in such diverse biological 
process by the TET proteins is still not precisely understood.  
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Figure 4. Schematic representation showing active DNA demethylation process 
catalyzed by the TET enzymes in Homo sapiens. 
Source image is adapted from Scourzic et al. (Scourzic et al, 2015). Figure was re-created using chem-
sketch due to copy right issue. 
 
 
1.2.3 TET isoforms and mechanism of action 
 
                   The mammalian TET family consists of three isoforms, namely TET1, TET2 
and TET3. The catalytic domain is evolutionarily conserved in all the TET isoforms and 
harbors a double-stranded β helix domain (DSBH) and a cysteine-rich region before 
the DSBH (Melamed et al, 2018). The DSBH domain serves as binding site for protein-
protein interaction and harbors binding sites for the cofactors 2-oxoglutarate (2-OG) 
and Fe (II) (Wu & Zhang, 2017).  The cysteine-rich domain contains the binding site 
for the metal Zn++, which provides stability to the overall structure of TET proteins (Wu 
& Zhang, 2017). Unlike other cysteine-rich domain-containing proteins, the TET 
proteins cysteine-rich region does not form an independent motif but instead enfolds 
within the DSBH (Yin & Xu, 2016). The TET proteins employ a flipping mechanism to 
position the methylated cytosine to their catalytic pocket. Once flipped into a precise 
position, the target base orients towards the Fe++ and 2-OG catalyzing the DNA 
oxidation reaction. The amino terminus of both TET1 and TET3 contains the CXXC 
domain, which is involved in binding to methylated CpG sites (Melamed et al, 2018). 
However, TET2 lacks a conserved CXXC domain, which is hypothesized to be missing 
due to gene conversion and duplication events during evolution (Akahori et al, 2015). 
Recent studies demonstrate that TET2 can still bind to the DNA with the help of IDAX 
domain (Ko et al, 2013). The difference in TET proteins is not confined to its structure 
but also to their distinct expression pattern around a wide range of tissues (Melamed 
et al, 2018).  
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Figure 5. Schematic illustration of TET enzymes in Homo sapiens. 
Source image is adapted from Pastor et al. (Pastor et al, 2013), Copy right license number 
4704840422098. There are three isoforms of TET proteins, namely TET1, TET2 and TET3. All TET 
isoforms have a conserved catalytic domain in the C-terminus. TET1 and TET3 have CXXC domain in 
their N-terminus, which is absent in TET2.  
 
 
1.2.4 Role of TETs in cardiovascular diseases 
 
                    One of the primary functions of TET enzymes is their ability to 
hydroxymethylate DNA. Emerging evidence shows that the change in DNA 
hydroxymethylation pattern is associated with increased cardiac hypertrophy in a 
pressure overload model of heart failure (Greco et al, 2016). Change in DNA 
hydroxymethylation pattern suggests an alteration in the expression of TET enzymes. 
TET enzymes are thus emerging as new players in cardiovascular diseases (Felisbino & 
McKinsey, 2018). Studies demonstrate that loss of TET2 results in aggravation of 
inflammation and ameliorates endothelial cell dysfunction in atherosclerotic mouse 
models (Liu et al, 2013). Another study shows that loss of TET2 in hematopoietic or 
myeloid cells in pressure overload-induced heart failure models worsens cardiac 
fibrosis and concomitant increase in the expression of interleukin-1beta (IL-1β) (Fuster 
et al, 2017). The findings support that mutations in TET2, in hematopoietic or myeloid 
cells are associated with increased risk of coronary heart diseases (Fuster et al, 2017). 
 
Additionally, a study by our group demonstrates that BMP7 mediated expression of 
TET3 can rescue cardiac fibrosis via re-expression of RASAL1 (an essential gene 
silenced during cardiac fibrosis) in pressure overload-induced mouse model (Xu et al, 
2015). Another study shows adverse maternal environment (AME) alters TET 
expression in the heart and increases the risk of cardiac fibrosis (Spearman et al, 2018). 
However, it is interesting to note that so far, there are no reports to link the role of 
TET1 in cardiovascular diseases (Spearman et al, 2018). Since the heart is comprised 
of a heterogeneous population of cells, it is not entirely clear whether TET isoforms are 
expressed globally or in a cell type-specific manner. Moreover, recent studies in cancer 
models demonstrate that all the isoforms of TET orchestrate different functions, so it 
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would be interesting to understand the role of TET proteins as facilitators or effectors 
of cardiovascular disease progression (Rawluszko-Wieczorek et al, 2015). 
  
 
 1.3 DNA DAMAGE 
 
                    Exposure to a variety of endogenous as well as exogenous stimuli poses a 
constant threat to the genomic DNA to form DNA lesions (Norbury & Hickson, 2001). 
Depending on the source, the DNA lesions generated can either be single-stranded or 
double-stranded. DNA is the blueprint of life (Hakem, 2008). Unrepaired DNA lesions 
can lead to increased replication stress, mutations, decreased proliferation, premature 
apoptosis, threatening the genomic integrity and hence the survival of the cell itself 
(Eastman & Barry, 1992). To ensure genomic stability, cells have evolved stringent 
checkpoints and associated DNA damage repair response (Zhou & Elledge, 2000). The 
DNA damage repair response is a highly dynamic and complicated process. It is 
regulated at three fundamental levels by a distinct set of proteins (Maréchal & Zou, 
2013). 
 
(i) Sensors- recognizing the DSBs (e.g. mre11-rad50-nbs1 complex)  
(ii) Transducers- signalling at the DSBs (e.g. ATM and ATR)  
(iii) Effectors and mediators- repair factors recruited at the DSBs (e.g. 53BP1 or 
      RAD51), cell cycle checkpoint kinase activators in response to DSBs (e.g. CHK1 and  
      CHK2).  
 
A flaw in any of these fundamental points may contribute to disease and affects cell 
survival. 
                               
Figure 6. Schematic representation of DNA damage repair response. 
Source image is adapted from Srinivas et al. (Srinivas et al, 2019). Copy right license is not required, as 
the publisher granted the represented image free to be reused. 
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1.3.1 DNA repair response 
 
                      Of all the types of DNA lesions encountered by the cells, DSBs poses an 
extreme threat, and if left unresolved becomes harmful for the survival of the cells 
(Mehta & Haber, 2014). DSBs in cells are repaired predominantly by the two redundant 
repair response pathways NHEJ (Non-Homologous-End-Joining) and Homologous 
recombination (HR) (Kakarougkas & Jeggo, 2014).  
 
 
1.3.2 Non-Homologous-End-Joining repair response pathway 
 
                      NHEJ is a template-independent fast DDR response pathway that 
mediates direct ligation of two broken ends of DNA (Davis & Chen, 2013). NHEJ 
operates in a template-independent manner; hence, it is actively available to resolve 
DNA DSBs in all phases of the cell cycle (Davis & Chen, 2013; Delacote & Lopez, 2008). 
The NHEJ works in four sequential steps described 
 
      i. DNA damage end recognition and assembly of NHEJ repair factors at DSBs.   
     ii. Promotion of stability around DSBs.   
     iii. Short DNA end processing.   
     iv. End ligation of broken and processed DNA ends.    
 
The first step in NHEJ is the recruitment of Ku heterodimers to the sites of DSBs. Ku 
heterodimers have a very high affinity (binding constant of 2×109 M−1) towards binding 
to broken DNA DSBs ends (Lee et al, 2016). Ku heterodimer are comprised of Ku70 
and Ku80 subunits After binding to DNA ends, Ku complex serves as a docking site for 
the recruitment of nucleases and NHEJ core repair factors (Lee et al, 2016). The next 
step facilitated by the Ku complex is to promote the stability around DSBs to prevent 
the untimely collapse of the DNA ends (Krasner et al, 2015).  DNA stability at the 
broken ends, in part by Ku complex, is facilitated by the recruitment of the catalytic 
subunit of DNA dependent protein kinase (DNA-PKcs) (Lee et al, 2016). Upon binding 
to DNA DSBs, DNA-PKcs gets auto-phosphorylated, which in turn facilitates the 
phosphorylation of NHEJ repair factors like 53bp1 (Callén et al, 2009). DNA-Pkcs not 
only promote phosphorylation of repair proteins but also timely recruitment and 
release of nucleases such as Artemis to enable proper trimming of broken ends (Jiang 
et al, 2015). Once the broken DNA ends are processed, DNA polymerases Polμ or Polλ 
are recruited to fill the gap (Ramsden, 2011). The last and essential step in NHEJ is to 
ligate the processed broken ends. The process initiates via recruitment of scaffolding 
protein XRCC4 which forms a docking site for the recruitment of DNA ligase IV 
(Ahnesorg et al, 2006). XRCC4 stabilizes DNA ligase IV by promoting its adenylation 
(Davis & Chen, 2013). NHEJ pathway is active throughout the cell cycle (Davis & Chen, 
2013). However, it is highly favored to operate in G1 cells. NHEJ is a fast repair process 
but it is error-prone and can also result in increased insertions, deletions and 
substitutions (Davis & Chen, 2013). 
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Figure 7. Schematic representation of NHEJ-mediated DNA repair pathway. 
Source image is adapted and modified from Iliakis et al. (Iliakis et al, 2015). Copy right license number 
1002992-1. In response to DNA DSBs, KU70 heterodimer complex is recruited to the site of DNA 
damage. KU70 complex in turn recruit’s DNA-PKcs and other DNA end processing enzymes that aid in 
stabilizing the DNA breaks and prepare for repair. DNA polymerases are recruited to fill in the gaps and 
in the end DNA ligase4 and XRCC4 help in ligating the broken ends. 
 
1.3.3 Homologous-Recombination repair response pathway 
 
                   HR is a slow, template-dependent high-fidelity DDR response pathway that 
predominantly operates in the S and G2/M phases of the cell cycle (Norbury & Hickson, 
2001).  HR plays a crucial role in maintaining genomic integrity in mitotically active 
cells (Moynahan & Jasin, 2010). Additionally, HR facilitates recovery from stalled 
replication forks, implicating their role in avoiding unwanted replication stress (Ait 
Saada et al, 2018). HR works in four sequential steps described as  
 
i. Enzymatic resection of DNA DSBs end. 
ii. Recruitment of nucleoprotein filaments to stabilize broken DNA ends. 
iii. Search for homologous daughter strand, followed by invasion to initiate repair of 
the broken DNA ends. 
iv. Synthesis of DNA repair at the DSBs. 
v. Resolution of repair intermediates to complete the repair at DSBs. 
 
The first step in the HR repair response is the processing of broken DNA ends to 
generate 3’ single-stranded DNA (ssDNA) overhangs. This process is widely known as 
DNA end resection and is carried out by the action of 4 enzymes (Huertas, 2010). 
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(a) MRN complex, 
(b) Exonuclease 1 (EXO1), 
(c) DNA2, and  
(d) CtBP-interacting protein (CtIP).  
 
Once the ssDNA ends are generated, heterotrimeric Replication Protein A (RPA) 
complex recruits to the 3’ ssDNA end to prevent the formation of loops and secondary 
structures (Polo & Jackson, 2011). Recruitment of RPA complex follows the loading of   
RecA, E. Coli and Homolog of Recombination Protein A (RAD51). RAD51 is an 
essential monomeric protein complex that binds to the resected end of ssDNA tails and 
facilitates sister-chromatid strand invasion (Ma et al, 2017). Completion of strand 
invasion is followed by the formation of displacement loop (D-loop). In the end, 
replicative polymerase δ uses the invading strand as a primer to initiate DNA synthesis 
to fill up the gaps (Delacote & Lopez, 2008). 
 
                                           
 
Figure 8. Schematic representation of HR-mediated DNA repair pathway. 
Source image is adapted and modified from Iliakis et al. (Iliakis et al, 2015). Copy right license number 
1002992-1. In response to HR mediated DNA repair, MRN complex is recruited to the site of DNA DSBs. 
MRN complex in turn recruits BRCA1, CtIP to process the DNA ends. Such processing of DNA ends is 
known as DNA end resection and it plays a key role in recruiting RPA1 and RAD51 to mediate homology 
strand search and initiate DNA repair. In the end, resolvases and DNA ligating enzymes are recruited to 
complete the ligation process.   
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1.4 ROLE OF DNA DAMAGE AND REPAIR IN CARDIOVASCULAR 
DISEASES 
 
                    Studies highlighting the role of DNA damage as an independent factor for 
the development of cardiovascular diseases are emerging. In line with these 
observations, it is reported that Ku70-/- (Ku70 is an essential component of NHEJ 
DDR response) knockout in mice results in cardiac hypertrophy. Similarly, ATM-/- 
(the upstream DNA damage sensor kinase) knockout in mice aggravates the 
progression of cardiac fibrosis (Foster et al, 2012). A recent study in pressure overload-
induced mouse model demonstrates loss of XRCC1 and PARP1 in cardiomyocytes 
causes increased single-stranded break accumulation and acute inflammation in the 
failing heart (Higo et al, 2017). 
 
Interestingly, the presence of single nucleotide polymorphism in DNA repair genes is 
also associated with an increased risk of cardiovascular diseases. Such as single 
nucleotide polymorphism in the RAD52 gene (involved in HR repair) increases the risk 
of mortality in cardiovascular patients (Lenart et al, 2017). Single nucleotide 
polymorphism in BRAP2 (a protein involved in HR) is associated with increased risk 
of myocardial infarction. Similarly, single nucleotide polymorphism in BRAP2 causes 
right ventricular hypertrophy (Ozaki et al, 2009). A study in anthracycline-induced 
cardiac failure demonstrates BRCA2 (a protein involved in HR) deficiency promotes 
cardiomyocyte apoptosis (Singh et al, 2012). 
 
Additionally, failing or aging hearts are also reported to demonstrate a decrease in 
NHEJ efficacy in cardiac fibroblasts (Vaidya et al, 2014). Loss of function studies show 
that HMGB1 (a non-histone chromatin protein) is associated with increased clearance 
of DNA DSBs in a fibrotic heart (Takahashi et al, 2019). An exciting aspect of all of 
these studies is that the role of DNA damage and repair responses are widely studied 
mostly in cardiomyocytes. However, the impact of DNA damage on cardiac fibroblasts 
is not entirely clear. Hence, more investigation is necessary to understand the role of 




 1.5 ROLE OF TGF-β IN DNA DAMAGE AND REPAIR RESPONSES 
 
                     TGF-β is a pleiotropic cytokine that coordinates several cellular processes 
(Liu et al, 2017). TGF-β is also emerging as one of the new players in facilitating DDR 
responses (Barcellos-Hoff & Cucinotta, 2014). Studies in murine keratinocytes 
demonstrate loss of TGF-β contributes to the genomic instability independent of p53 
activation (Lin et al, 2012). Studies show that loss of TGF-β in a human microvascular 
endothelial cell line drives centrosome aberration and aneuploidy (Langenkamp & 
Molema, 2009). Similarly, smad4 deficiency in the presence of TGF-β signalling in 
murine lung tumors impairs clearance of DNA DSBs (Haeger et al, 2016). Increased 
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expression of TGF-β in MDA-MB231 cells is reported to decrease HR repair efficacy 
but results in decreased DNA DSBs due to its effect on downregulating the damage 
sensors ATM and MSH2 (Pal et al, 2017). Interestingly, in A431 carcinoma cells, TGF-
β is reported to increase the cell survival against ionizing radiation-induced DNA DSBs 
via switching to accelerated NHEJ DDR (Lee et al, 2016). The same study also 
demonstrates that such accelerated NHEJ in A431 cells is due to increased expression 
of Lig4, a key NHEJ repair factor (Lee et al, 2016). Apart from its role in HR and NHEJ, 
studies have also demonstrated active involvement of TGF-β in NER and alt-NHEJ 
(Liu et al, 2018; Zheng et al, 2019). Altogether these results show that aberrant TGF-β 
signalling poses a potential threat to genomic instability due to impact on the DNA 
damage and repair response. Increased expression of TGF-β is known to contribute to 
activation and proliferation of cardiac fibroblasts during fibrosis (Liu et al, 2017). 
However, the contribution of TGF-β in facilitating the DDR response in the fibrotic 
fibroblast has not been studied.  
 
 
1.6 ROLE OF TETs IN DNA DAMAGE AND REPAIR RESPONSES 
 
                    TET (TET1/2/3) proteins are emerging players in orchestrating the DNA 
damage and repair responses in eukaryotic cells (Chen et al, 2018; Kuhns et al, 2019; 
Zhang et al, 2017). A study in glial cells shows loss of TET1 results in activation of G2M 
arrest and harbors endogenous increase in DNA DSBs even in the absence of genotoxic 
stress (Coulter et al, 2017; Kuhns et al, 2019). A study in mouse embryonic stem cells 
demonstrates that TET1 forms a complex with Sin3a and MOF to regulate the 
expression of DNA repair genes (Zhong et al, 2017). Notably, the same study reports 
that loss of TET1 also leads to increased DNA DSBs in the absence of external DNA 
damage, which is consistent with the previous observation in human glial cells (Coulter 
et al, 2017; Zhong et al, 2017). Loss of TET1 results in a decrease in both HR and NHEJ 
efficacy, suggesting their role in DNA DSBs repair response pathways (Zhong et al, 
2017). In p53 mutated lung cancer cell lines, knockdown of TET1 is reported to result 
in increased DNA damage, slower cell growth, and increased genomic instability 
(Filipczak et al, 2019). In mouse Purkinje cells ATM-mediated stabilization of TET1 is 
reported to contribute to efficient repair of DNA DSBs (Jiang et al, 2015). 
 
In myeloid malignancies, TET2 mediated hydroxymethylation results in recruitment 
of MSH6 (a protein involved in DNA mismatch repair) to the DNA damage sites 
(Greenberg et al, 2017). Moreover, a study shows loss of TET2 causes defects in 
chromosome segregation and decrease of BRCA2 (involved in HR repair) mRNA 
expression (Kafer et al, 2016). In human bone osteosarcoma epithelial cell lines TET2 
interacts with SMAD nuclear interacting protein 1 (SNIP1) to regulate the expression 
of DNA damage repair genes (Chen et al, 2018). Additionally, a recent report 
demonstrates that ATR mediated stabilization of TET3 is involved in DNA repair 
(Jiang et al, 2017). The same study further reports that TET3 facilitates DNA repair via 
its catalytic activity to form new 5hmC marks at sites of DNA damage and its loss 
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harbors increased endogenous DNA damage. However; the study sheds no light on 
whether TET3 is recruited directly to the DNA damage sites or its involvement in the 
choice of DNA repair (Jiang et al, 2017). A TET2 and TET3 double knock out in myeloid 
cells is also reported to increase DNA DSBs in the absence of external damage (An et 
al, 2015). The same study also demonstrates change in expression of DNA repair genes 
in the state of TET2 and TET3 double knockout. Altogether, these studies clearly show 
an association between the interplay of TETs and DNA damage repair response 
proteins in facilitating or fine-tuning the DNA repair to ensure genomic instability. 
However, how the cells decide to use the TET isoforms in different phases of DNA 
repair is not entirely clear and needs further investigations. 
 
1.7 AIMS OF THESIS 
 
The fibrotic microenvironment regularly produces ROS and cytokines that 
continuously damage the DNA resulting in production of SSBs or DSBs. DSBs are 
highly deleterious lesions and so far, their effect on cardiac fibrosis are not entirely 
clear. Notably, in response to DSBs most cells are programmed to halt the cell cycle 
until the DNA lesions are resolved. However, cardiac fibroblasts proliferate in an 
increased DNA DSBs niche during fibrosis. Therefore, it is important to understand 
how fibroblasts are able to proliferate despite increased DNA damage. The fibrotic 
progression is also associated with change in epigenetic marks. In line with these 
observations, our group has previously observed that TET3 can ameliorate fibrotic 
progression in both murine models of cardiac and renal fibrosis. Recent studies are 
highlighting a role of TET3 in DNA damage and repair response. These observations 
lead us to hypothesize that TET3 may prevent aberrant proliferation of fibroblasts via 




1. a potential association of TET3 and DNA damage in healthy and fibrotic cardiac 
fibroblasts 
 
2. the role of TET3 in engaging the choice of DNA repair in healthy and fibrotic 
cardiac fibroblasts 
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2. MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Cell line 
 
 



















2.1.2 Cell culture media and additives 
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2.1.3 Chemicals and reagents 
 
All chemical and reagents used throughout the experiments are enlisted in Table 3. 
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Thermo Fisher Scientific 
 
269620 
Black coated  
96-well plates 
 











Thermo Fisher Scientific 
 
174952 
12 well 4-12 % 
SDS PAGE gel 
 




Falcon Tubes 15 mL 
 




Falcon Tubes 50 mL 
 

































































2.1.5 Recombinant proteins 
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Table 8. List of buffers used in the study. 
 
 
Alexa Fluor ® 568 
donkey anti-rabbit 
Life Technologies 1:500 A-32795 





































2 % BSA in 1X PBS 
 
2g of BSA in 100 ml of PBS 
10 % BSA in 1X 
PBS 
 





137 mM NaCl  
2.7 mM KCl  
4.3 mM Na2HPO4·7H2O  








140 mM NaCl 
3.6 mM KCl  
0.5 mM NaH2 PO4 
0.2 mM MgSO4  
1.5mM CaCl2 
10 mM Hepes (pH 7.4)  






137 mM NaCl  
2.7 mM KCl  
4.3 mM Na2HPO4·7H2O  




20 mM Tris 




20 mM Tris 
150 mM NaCL 
0.1% Tween-20, pH 7.4 
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2.1.8 Primers 
 
Table 9. List of primers used in the study. 
 
 
2.1.9 Commercial Kits                        
 












































GAT CGA TGG CCA GCA CGG 
ATG AGT TG 
AAA ACA ACT CAT CCG TGC 





GAT CGT GTC TTC CCC TCC CAG 
TTC CG 
AAA ACG GAA CTG GGA GGG 
GAA GAC AC 
 
10 μM 
Name Source Order No. 
 




































Pierce BCA Protein Assay Kit  
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2.1.10 Plasmids     
  





Table 12. List of equipment used in the present study. 
 
 































































Name Use Company 
 


















Bright light microscopy 
 












Visualisation of protein 
 
Biorad 
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camera Color View 
Visualisation of 











Bright field  
visualisation of cells 
 























































StepONE Plus  
Real-Time PCR System 
 



































Bender & Hobein AG 
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2.2 METHODS 
 
2.2.1 Human myocardial tissue sections 
 
All patient samples are collected from the Department of Cardiology, UMG Gottingen, 
in accordance with ethical rules and regulations of the Institutional Review Board of 
the University of Göttingen and the responsible government authority of Lower Saxony 
(Germany). 
 
2.2.2 Animal welfare and ethics statement 
 
All experimental animal studies were conducted in accordance with the guidelines of 
the experimental protocols and ethical rules approved by the Institutional Review 
Board of the University of Göttingen and the responsible government authority of 
Lower Saxony (Germany). The animal protocols used in these experiments conformed 
to the guidelines in Directive 2010/63/EU of the European Parliament on the 
protection of animals.  
 
2.2.3 Fibrosis induction using angiotensin II osmotic minipump in mice  
 
The angiotensin II model was implemented as described. Briefly, 14- to 16-week–old 
C57/BL/6N mice with body weights between 25 g and 30 g were used for angiotensin 
II (Ang-II) pump implantation experiments. Ang-II (1.5 mg/kg per day), or PBS as the 
control, was administered to the animals, using an osmotic minipump (ALZET Model 
1002), for 4 weeks.  
 
2.2.4 Cell culture 
 
Mouse primary cardiac fibroblasts (MCFs) were obtained from Cell-Science. The cells 
were cultured using 1.5 g Glucose Dulbecco's Modified Eagle Medium (DMEM) 
supplemented with 10% fetal bovine serum, sodium pyruvate (1 mM), nonessential 
amino acids (0.1 mM), penicillin (100 units/ml), and streptomycin (0.1 mg/ml). The 
cells were maintained at 37°C in 5% CO2 and cultured until passage 4. All the 
experiments were conducted in either the second or the third passage. Mycoplasma 
contamination was routinely checked during the entire course of the experiment. 
 
2.2.5 Neocarzinostatin (NCS) and transforming growth factor beta (TGF-
β) treatment 
 
The MCFs cells were treated with either 100 ng/ml of neocarzinostatin (NCS, Stock 0.5 
mg/mL) or 15 ng/mL of transforming growth factor beta (TGF-β) or 100 μM of H202 
(H202, Stock- 9.8 M) in all subsequent cell culture experiments. 
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2.2.6 Generation of clustered regularly interspaced short palindromic 
repeats/CRISPR-associated protein 9 (CRISPR/Cas9) Tet methylcytosine 
dioxygenase 3 (TET3) knockdown constructs 
 
The clustered regularly interspaced short palindromic repeats/CRISPR-associated 
protein 9 (CRISPR/Cas9) backbone was used to generate tet methylcytosine 
dioxygenase 3 (TET3) gene knockdown constructs in the MCFs. Guided RNAs 
targeting exon 10 and exon 11 of the TET3 gene were designed, and off-target binding 
effects were minimized on the basis of scores obtained on the online tool Blueheronbio 
(OriGene, Herford, Germany). The single-guide RNA (sgRNA) sequences were 
inserted into the pLenti-Cas9-Guide plasmid (OriGene GE100010, Herford, Germany) 
with BamHI and BsmBI restriction sites to generate p-Lenti-Cas-sgRNA mTET3 
constructs and confirmed by DNA sequencing. The deletion of the flanked exon was 
predicted to lead to a frameshift mutation, eventually resulting in the generation of a 
premature spliced transcript, leading to decreased protein expression. 
 
2.2.7 Plasmid isolation using midi-prep kit 
 
The HiSpeed® Plasmid Midi Kit from QIAGEN (Hilden, Germany) was used for the 
isolation of the plasmid. Bacterial cells cultured overnight were centrifuged at 4600 
RPM for 20 mins. The supernatant was discarded in bacterial waste, and the pellets 
were resuspended in 6 ml Buffer P1, which had been stored at 4°C. Next, 6 ml of Buffer 
P2 was added and incubated for 5 minutes at room temperature. Another 6 ml of Buffer 
P3 was subsequently added, and the tubes were inverted several times. Afterward, the 
liquid was transferred to barrel tubes (part of the kit) and incubated for 10 minutes. 
During this incubation step, the HiSpeed® Tips were equilibrated with 4 ml of ABT-
buffer. At this point, the lysate was filtered into the equilibrated Tip and was washed 
with 20 ml of Buffer QC. The elution was then performed with 56°C-prewarmed QF 
Buffer. The DNA was precipitated with 3.5 ml of isopropanol after 5 minutes of 
incubation. The eluate was filtered through the QIA precipitator; it was then washed 
twice with 80% ethanol. After the outlet nozzle was dried for 3 minutes, the plasmid 
was eluted in 800 µl of nuclease-free water. Finally, the DNA concentration was 
measured by Nano Drop.  
 
2.2.8 In vitro transfection  
 
The night before transfection, 50000 cells per well were seeded in a 6-well culture plate 
in an antibiotic-free DMEM (Gibco, Carlsbad, USA) well supplemented with 10% heat-
inactivated fetal bovine serum (FBS, Sigma-Aldrich, St. Louis, USA). For the 
knockdown experiments, 2.5 µg of pLenti-cas9 TET3 plasmid DNA was transfected; 
for over-expression, 2.5 µg of mouse TET3 plasmid DNA was transfected using 
Lipofectamine 2000 reagent (Invitrogen, Carlsbad, USA).  A total of 4 hours after 
transfection, the medium in each well was replaced by a fresh antibiotic-free medium 
and allowed to incubate for the next 48 hours. 
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2.2.9 Histology 
 
Paraffin-embedded specimens were sectioned at 3 µm; Masson’s trichrome stain 
(MTS) was performed at as per the established protocol in lab (Tampe et al, 2015). For 
morphometric analysis of interstitial fibrosis, fibrotic areas were assessed using cell 
Sens (Olympus, Tokyo, Japan) software. A total of 10 visual fields were randomly 
selected for each MTS stained section at 200x magnification, and the relative 




Formalin-fixed, paraffin-embedded mouse heart sections were de-paraffinized in 
xylene and rehydrated in ethanol containing distilled water. Masson’s trichrome 
staining and fibrotic area quantification were performed as previously described in our 
publications. The sections were stained using the polyclonal antibody against TET3 
(GeneTex, Irvine, California, United States). The Vectastain Universal Elite ABC Kit 
(Vector Laboratories, Burlingame, California, United States) was used for performing 
peroxidase labelling. The area of interest was visualized using AEC Substrate-
Chromogen (Dako, Glostrup, Denmark) according to the manufacturer’s protocol, and 
nuclear staining was performed using Mayer’s Hematoxylin Solution (Sigma-Aldrich, 
St. Louis, Missouri, United States) as previously described. 
 
2.2.11 Single-cell, neutral gel electrophoresis 
 
Neutral comet assay was performed on the whole mouse hearts and in vitro in mouse 
cardiac fibroblasts (MCFs).  Briefly, isolated cells from the mouse hearts or MCFs were 
mixed with 1% low-melting agarose gel. The resulting solution was then poured on a 
chilled precoated agarose glass slide. The cells were then lysed overnight at 4°C in lysis 
solution (Trevigen, 4250-010-01). The next day, the slides were run in the freshly 
prepared neutral running buffer (Trevigen, 4250-050-K) for 30 minutes at 12 V.  Post-
electrophoresis, SYBR Safe was added to visualize the comet tails using a fluorescent 
microscope. 
 
2.2.12 Amplex Red assay 
 
The H2O2 concentration in the mouse hearts was measured using the Amplex Ultrared 
dye according to the manufacturer’s instructions. In brief, the mouse hearts were 
minced into small pieces (20 mg) and incubated with Amplex Red and Krebs Hepes 
Buffer at a concentration of 100 μmol/L and horseradish peroxidase at a concentration 
of 1 U/mL for 60 min in the dark. The supernatant was collected immediately after 
incubation and transferred to a black-coated 96-well plate, and fluorescence was 
measured at 560nm. 
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2.2.13 Protein extraction and quantification 
 
Proteins were extracted from the cells by using 100 µL of NP-40 buffer, pre-added with 
protease inhibitor tablets (ROCHE). The extracted proteins were sonicated at 40 
amplitude for 10 minutes, with 15 seconds on and off-cycle. After that, the samples 
were centrifuged at 13000 RPM at 4°C. The supernatant was collected in a fresh 1.5 mL 
Eppendorf tube for further use. 
 
The extracted proteins were quantified using bicinchoninic acid (BCA) protein 
estimation kit. This method relies on an alkaline medium where the reduction of 
cuprous ion to cupric ion takes place in the presence of protein. As a result of such a 
reaction, a purple-coloured product is formed due to the chelation of two molecules of 
BCA with one molecule of cuprous ion. The concentration of the protein is thus 
quantified as a measure of absorbance at 562nm. 
 
 
2.2.14 TET and glutathione/glutathione disulfide (GSH/GSSG) activity 
assays 
 
Both activity assays were performed in the mouse hearts as per the manufacturer’s 
instructions (ab156913, ab138881). Briefly, 20 μg of tissue were collected and minced 
into small pieces with the help of a surgical scalpel. For testing both TET and 
GSH/GSSH activity, the small tissue pieces were first lysed for 1 hour at 4 °C in nuclear 
lysis solution, provided in the respective kits. After completion of lysis, for analyzing 
TET activity assay, 2 μL of 0.5X TET Substrate was added and incubated at 37°C for 90 
min. Then, 50 μL of the capture antibody were added to the samples (1:1000 from 
stock). The samples were further incubated at 37°C for 60 minutes. Thereafter, samples 
were washed thrice with 1X wash buffer and then incubated with 50 μL of the Diluted 
Detection Antibody. The samples were further washed thrice with 1X wash buffer. After 
that, 100 μL of developer solution was added, and the samples were incubated for 15 
minutes. In the end, 50 μL of stop solution was added, and absorbance was measured 
using ELISA plate reader at 450 nm.  
For GSH/GSSG assay, 50 μL of GSH Assay mixture were added into each GSH 
standard and sample well. For total GSH + GSSG (reduced and oxidized), 50 μL of total 
glutathione Assay mixture were added into each GSSG standard and sample. After that, 
the samples are incubated at room temperature 45 minutes in the dark. In the end, 
absorbance was measured using ELISA plate reader at 490 nm.   
 
2.2.15 Immunofluorescence  
 
A total of 10 000 cells per chamber were seeded in the 8-well chambered slides. Before 
fixing, the slides were washed twice with 1X PBS. Fixing was performed using 4% 
paraformaldehyde (PFA) for 15 minutes at room temperature. Post-fixation cells were 
permeabilized with 0.1% phosphate-buffered saline with Tween 20 (PBST) (1XPBS + 
Triton X 100) for 7 minutes; they were then washed twice in 1X PBS. The cells were 
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blocked with 5% bovine serum albumin (BSA) in PBST for 1 hour at room temperature. 
Post-blocking, the cells were incubated with respective primary antibodies dissolved in 
1% BSA in PBST overnight at 4°C. The next day, the cells were washed thrice with 1X 
PBS and thereafter incubated with secondary antibody dissolved in 1% BSA in PBST 
for 1 hour. The cells were rewashed thrice with 1X PBS and mounted with 4′,6-
diamidino-2-phenylindole (DAPI) to be visualized under the microscope.  
 
2.2.16 Confocal image analysis 
 
All images were photographed using an LSM780 confocal microscope. Triple-stained 
images were taken using settings in the frame with either Alexa green 488, Alexa red 
568, or Alexa infrared 647 lasers. All the images represented were processed using ZEN 
blue software (ZEISS, Oberkochen, Germany), keeping the parameters constant. The 
nuclei of all the represented images were visualized with the DAPI channel. 
 
2.2.17 RNA isolation 
 
For the purpose of isolating the RNA from the samples, 700 µl trizol was first added, 
and the cells were completely resuspended. They were incubated for 15 minutes on ice. 
Afterward, 250 µl of chloroform was added, and the tubes were shaken at least 7 times. 
They were then incubated for 7 minutes at room temperature. The phases were 
separated during centrifugation for 20 minutes with 15000 RPM at 4°C. The aqueous 
phase was then separated, and an equal amount of 70% ethanol was added. The 
resulting solution was transferred to spin cartridges, which are part of the Pure Link™ 
RNA Mini Kit. The cartridges were centrifuged for 2 minutes with 15000 RPM at 4°C 
to fix the RNA on the filter; they were then washed with wash buffer I and centrifuged 
for 30 seconds. The RNA was washed 2 more times with wash buffer II and centrifuged 
for 30 seconds. The filter was dried by centrifugation for 2 minutes with no solution 
added. Additionally, it was dried for 2 minutes by passive evaporation. After 2 minutes 
of incubation, the RNA was eluted with 30 µl of 56°C-prewarmed nuclease-free water 
by centrifugation for 2 minutes in fresh Eppendorf tubes. Finally, the RNA 
concentration was measured by Nano Drop. 
 
2.2.18 Complementary DNA synthesis 
 
To analyze the isolated cellular transcripts, the RNA was converted into 
complementary DNA (cDNA). First, the isolated RNA was diluted in nuclease-free 
water to yield a final RNA amount of 1 µg. Next, 1 µl of 10x reaction buffer and 1 µl 
deoxyribonuclease I (DNase I) were added to the diluted RNA, which was then 
incubated for 15 minutes at room temperature. At the end, 1 µl of stop solution was 
added. Afterward, the samples were heated to 70°C for 10 minutes; they were then 
cooled on ice. In the next step, 1 µl of 10mM deoxyribonucleoside triphosphate (dNTP) 
and 1 µl of 100 µM oligo(dT) per sample were added and incubated for 5 minutes at 
65°C. Next, 4 µl 5x first-strand buffer, 2 µl of 0.1 M dithiothreitol (DTT), and 1 µl 
RNaseOUT (20U/μL) were added, and the RNA was incubated for 2 minutes at 42°C. 
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Finally, 1 µl of Superscript® Reverse Transcriptase (20U/μL) was added per sample. 
The reaction was left at 42°C for 50 minutes and at 70°C for 15 minutes. The cDNA was 
frozen at -80°C before use.  
 
2.2.19 Real-time quantitative polymerase chain reaction (RT-qPCR) 
 
Real-time quantitative polymerase chain reaction (RT qPCR) was performed using 
SYBR Green Master Mix on Applied Biosystems StepOne software v2.3. Briefly, the 
RNA was isolated from the tissues or the cells using the PureLink RNA isolation kit, 
and cDNA was synthesized using the Invitrogen cDNA synthesis protocol. Validated 
primers were used to analyze the change in gene expression. The forward and reverse 
primers of each gene were mixed in nuclease-free water (primer concentrations are 
provided in Table 9). A master mix containing 6 µl of nuclease-free water, 2 µl of primer 
mix, and 10 µl of SYBR Green per sample was prepared, and 18 µl of the mix was added 
per well. Finally, 2 µl of cDNA in 1:20 dilution was added. After the plate had been 
closed airtight with Micro Amp™ Optical Adhesive Film, the samples were vortexed 
and centrifuged.  
 
The following program was used:   
     95°C 10 min 
     95°C 20 sec 
     60°C 30 sec 
 
The relative expression levels were calculated using the following equation: 2-delta-
delta Ct.  
 
2.2.20 Western blot 
 
Briefly, the cells were homogenized in nonyl phenoxypolyethoxylethanol (NP-40) lysis 
buffer (Life Technologies, Carlsbad, USA) supplemented with protease inhibitor 
cocktail (Roche, Basel, Switzerland) for 30 minutes on ice. Protein lysates were then 
sonicated and measured using a bicinchoninic acid (BCA) kit. Next, 50 µg of protein 
samples were loaded in a 4% to 12% Bis-Tris polyacrylamide gel electrophoresis system 
(Novex, Carlsbad, USA) and transferred onto a nitrocellulose membrane (GE 
Healthcare, Freiburg, Germany). The membranes were blocked with 5% bovine serum 
albumin in tris-buffered saline with Tween 20 (TBST) (tris-buffered saline (TBS) pH 
7.2, 0.1% Tween 20) and then combined with the TET3 antibody in 2% BSA in TBST 
overnight at 4°C. The next day, the membrane was washed 3 times in TBST and then 
incubated with the secondary antibody. Luminescence was detected using 
chemiluminescent substrate (Cell Signalling, Danvers, USA) on a ChemiDoc XRS 
system (Bio-Rad, Hercules, USA). The same membranes were restriped to show 
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2.2.21 Flow cytometry 
 
Briefly, the cells were washed with PBS twice before detachment with trypsin (1:3 
dilution, incubation for 2 to 4 minutes at 37°C). An equal amount of culture media was 
added to stop the reaction. The cell solution was centrifuged for 10 minutes with 1.200 
RPM, and the supernatant was discarded. Afterward, the cells were washed twice with 
ice-cold PBS; this involved carefully suspending them in 1 ml of PBS before 
centrifuging them with 1.200 RPM for 10 minutes. In a final step, the cells were 
suspended in 500 µl of ice-cold PBS. A total of 5 ml of 70% ethanol was added dropwise 
with constant vortexing. The cells were in single suspension after this procedure; they 
were frozen at -80°C overnight for at least 1 hour. In the next step, the suspension was 
centrifuged again for 10 minutes with 4600 RPM at 4°C. The supernatant was 
discarded, and the precipitate was resuspended in 500 µl of ice-cold PBS. The solution 
was transferred into Eppendorf tubes. Afterward, 500 µl of propidium iodide and 2 µl 
of ribonuclease A (RNase A) were added and mixed conscientiously. The suspension 
was incubated for 30 minutes at 37°C. Within 1 hour, the measurement was taken with 
BD Accuri TM C6 (BD Biosciences, San Jose, California, United States). 
 
2.2.22 Proximity ligation assay 
 
The cells were seeded at a density of 104 cells per well in an 8-chambered slide. The 
cells were fixed and permeabilized as described before in immunofluorescent studies. 
After permeabilization, the cells were incubated with blocking buffer provided in the 
mouse/rabbit red starter Duolink kit (Olink, Uppsala, Sweden) for 2 hours at 37°C in 
a humidified chamber. The primary antibodies were then conjugated with the probes 
provided within the kit and incubated for 1 hour at room temperature at 37°C in a 
humidified chamber. They were then washed 3 times in Buffer A (provided in the kit). 
The cells were then combined with amplification buffer and enzymes as per the 
manufacturer’s protocol and incubated for 90 minutes at 37°C in a darkened 
humidified chamber. Finally, the cells were washed with 1x Buffer B (supplied with the 
kit) for 10 minutes; this was followed by a 1-minute wash with 0.01X Buffer B. Finally, 
the cells were mounted using the DAPI conjugated mountant supplied with the kit. The 
red blobs indicated the proximity between 2 cellular-bound antibodies.  
 
2.2.23 Non-homologous end joining (NHEJ) and homologous 
recombination (HR) reporter plasmids 
 
The MCFs were stably transfected with 2.5 µg of circular pLCN-DSB or pDR-GFP 
(Addgene, Cambridge, USA) (Pierce et al., 1999; Seluanov et al., 2004). Resistant 
colonies were selected with 5 µg/mL of puromycin (ThermoFisher Scientific Scientific, 
Waltham, USA).  Transfection with I-SceI (pCBASceI, Addgene, Cambridge, USA) 
introduced a double-strand break (DSB) at genomic I-SceI sites of the reporter 
plasmid, which helped to restore the green fluorescent protein/enhanced green 
fluorescent protein (GFP/EGFP) signal, visualizing non-homologous end joining 
(NHEJ)/homologous recombination (HR) repair events. 
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2.2.24 Cell counting assay 
 
Briefly, the cells were counted using the trypan blue assay. The rate of proliferation was 
calculated as Rp = ln(N(t)/N (0))/t, where N(t) = the number of cells at time t, N 
(0) = the number of cells at time 0, and t = time (in days).  
 
2.2.25 MTT cell proliferation assay 
 
Briefly, 1000 cells were plated in a 96 well chambered plate and 20 μl of 5 mg/ml MTT 
was added to each well. One set of wells with MTT but without cells was taken as 
negative control. After addition of MTT, cells were left to incubate at 37°C for 4 hours. 
After incubation, media was removed and 100 μl of DMSO was added. Briefly, 10 
minutes within incubation, cells were measured for proliferation at 495 nm using an 
ELISA plate reader.  
 
2.2.26 Analysis of publicly available microarray datasets 
 
Datasets provided publicly were analyzed according to general recommendations, 
using Transcriptome Analysis Console software (Thermo Scientific, Waltham, 
Massachusetts, United States). Human transcriptome array data were shown as log2 
median-centered intensities extracted from database accession numbers GSE57345. 
2.2.27 BrdU DNA end resection assay  
 
Briefly, control, TET3 knockdown and TET3 rescued MCFs were incubated with 20 
mM of BrdU for 24 hours. Cells were fixed with 90 % ethanol in 1X PBS for 20 minutes.  
After fixation, cells were washed thrice with 0.1% PBST and then denatured with 2N 
HCl for 35 min. Cells were subsequently blocked with 10% FBS in 1X PBS for 1 hour at 
room temperature and thereafter washed thrice with 1X PBS. Subsequently, anti-BrdU 
secondary antibody from the BrdU kit was added and absorbance was measured in an 
ELISA plate reader at 370nM.  
 
2.2.28 Statistics 
Statistical analysis was performed using Graph Pad Prism 8 software. For comparing 
between two groups Welch unpaired two tailed Student's t-test was performed. For 
comparison of more than two groups, one-way ANOVA Bonferroni and Sidak test 
analysis was performed. Statistical significances are represented in the graphs as *p ≤ 
0.05, **p ≤ 0.01, *** p ≤ 0.001. 
 
TET3 impacts cardiac fibrosis partially via regulation of DNA damage response  
   
  
Sandip Kumar Rath  2019  Page 35 
3. Results 
 
 3.1 Mouse fibrotic hearts accumulate ROS and oxidative stress 
 
The fibrotic microenvironment is highly dynamic, and studies have shown that the 
increased ROS generation aggravates fibrosis (An et al, 2015). Chronic accumulation 
of ROS causes oxidative stress in the fibrotic hearts and leads to cytokine production 
and DNA damage (Mondal et al, 2013; Takimoto & Kass, 2007). H202 is one of the most 
prominent ROS that causes significant damage to fibrotic hearts (Guo et al, 2014; Qin 
et al, 2010; Steinhorn et al, 2018). The glutathione redox couple is the key buffer 
system that scavenges the H202 produced in the fibrotic heart (Swain et al, 2016). 
Increased ROS accumulation causes a shift in the ratio of reduced/oxidized glutathione 
(GSH/GSSG) (Sag et al, 2014). In line with these observations, we investigated the 
production of ROS (H202) and induction of oxidative stress in an angiotensin-II treated 
murine model of cardiac fibrosis. We confirmed fibrosis induction using Masson’s 
trichrome staining (MTS) (Figure 9A). Our results show a 1.7-fold increase in 
collagen deposition in fibrotic mouse hearts as compared to healthy control hearts 
(Figure 9B). We then confirmed a 3.7-fold increase in ROS generation using Amplex 
Red assay and a 1.67-fold decrease in the GSH/GSSG ratio, confirming accumulation 
of oxidative stress in fibrotic hearts (Figure 9C-D). Our results demonstrate that 
fibrotic mouse hearts have a significant increase in ROS and a decrease in the 
GSH/GSSG ratio compared to healthy mouse hearts. 
 
                      
 
Figure 9. Mouse fibrotic hearts have increased ROS and oxidative stress. 
(A) MTS staining showing collagen deposition (stained blue) in 4 weeks of sham and angiotensin-II 
treated mouse hearts. (B) Graph representing % of the fibrotic area in 4 weeks of sham and angiotensin-
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II treated mouse hearts. (C) Fluorescence measurement showing ROS intensity using Amplex Red assay 
in 4 weeks of sham and angiotensin-II treated mouse hearts. (D) Graph representing the change in 
GSH/GSSG ratio as an indicator of oxidative stress in 4 weeks of sham and angiotensin-II treated mouse 
hearts. Summarised quantitative findings are shown as mean ± SEM from 3 shams, and 3 Angiotensin-
II treated mouse hearts. Statistical significance was calculated using Welch unpaired two tailed Student's 
t-test, and P-values correspond to **p≤ 0.01. Scale bars represent 2 mm. 
 
 
3.2 Mouse fibrotic hearts have increased DNA damage 
 
Increased ROS and oxidative stress during cardiac fibrosis causes DNA lesions(Chen 
et al, 2019; Panth et al, 2016). Studies have confirmed that ROS-induced oxidative 
stress can cause both DNA SSBs and DSBs (AbdulSalam et al, 2016). The involvement 
of SSBs in heart failure is well understood, whereas the effect of DSBs in fibrotic 
progression is not clear (Higo et al, 2017). To confirm increased production of DSBs 
during fibrosis, we used γ-H2AX (a marker of DNA DSBs) staining. 
Immunohistochemical analysis shows significant production of DSBs in both myocyte 
and non-myocyte cell populations in the fibrotic mouse hearts (Figure 10). 
 
                      
Figure 10. Mouse fibrotic hearts have increased DNA damage. 
(A and B) Immunohistochemistry representative images and the respective graph shows the expression 
pattern of γ-H2AX in 4 weeks of sham and angiotensin-II treated mouse hearts. Summarised 
quantitative findings are shown as mean ± SEM from 3 shams, and 3 angiotensin-II treated mouse 
hearts. Statistical significance was calculated using Welch unpaired two tailed Student's t-test, and P-
values correspond to ** p≤ 0. 01. Scale bars represent 100 μm.  
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3.3 Mouse fibrotic fibroblasts show increased proliferation despite DNA 
damage 
 
Our immunohistochemical staining results demonstrate an increase in DNA DSBs in 
the non-myocyte cell population. Since fibroblasts comprise the most significant non-
myocytic cell population besides endothelial cells, we then assessed the presence of 
DNA DSBs in fibroblasts (Zhou & Pu, 2016). To confirm the accumulation of DNA 
DSBs in fibroblasts, we used γ-H2AX and α-SMA (a fibroblast marker) double 
immunofluorescent staining. Our results show an increase in the percentage of γ-
H2AX and α-SMA double-positive cells of total αSMA positive cells in fibrotic mouse 
hearts as compared to healthy sham hearts (Figure 11). 
 
                          
Figure 11. Mouse fibrotic fibroblasts have increased DNA DSBs. 
Confocal representative images and the respective graph shows double staining of γ-H2AX and α- SMA 
in 4 weeks of sham and angiotensin-II treated mouse hearts. Summarised quantitative findings are 
shown as mean ± SEM from 3 shams, and 3 angiotensin-II treated mouse hearts. Statistical significance 
was calculated using Welch unpaired two tailed Student's t-test, and P-values correspond to ***p≤ 0. 
001. Scale bars represent 20 μm. White arrow marks indicate γH2AX+, α-SMA+, and γ-H2AX/α-SMA++ 
cells at the indicated stages.  
 
Similarly, to assess increased proliferation in cardiac fibroblasts, we used Ki67 and α-
SMA double immunofluorescent staining. As expected, our results show an increase in 
Ki67 and α-SMA double-positive cells in the fibroblast population (Figure 12). 
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Altogether, these results demonstrate that the fibrotic fibroblasts can proliferate 
despite increased DNA damage. 
 
                        
 
Figure 12. Mouse fibrotic fibroblasts have increased Ki67 expression.  
 
Confocal representative images and the respective graph shows double staining of Ki67 and α-SMA in 4 
weeks of Sham and angiotensin-II treated mouse hearts. Summarised quantitative findings are shown 
as mean ± SEM from 3 shams, and 3 angiotensin-II treated mouse hearts. Statistical significance was 
calculated using Welch unpaired two tailed Student's t-test, and P-values correspond to ** p≤ 0. 01. 
Scale bars represent 20 μm. White arrow marks indicate Ki67+, α-SMA+, and Ki67/α-SMA++ cells at the 
indicated stages.  
 
 
3.4 Mouse fibrotic hearts lose TET3 expression  
 
Studies from our lab have shown that loss of TET3 is associated with aggravated organ 
fibrosis (Tampe et al, 2015; Xu et al, 2015; Xu et al, 2018). In line with these 
observations, we first confirmed the loss of TET3 in angiotensin-II treated mouse 
fibrotic hearts. Immunohistochemistry scoring and mRNA expression analysis 
demonstrate that TET3 is significantly downregulated in fibrotic mouse hearts as 
compared to control mouse hearts (Figure 13A-C). Additionally, 
immunohistochemistry scoring shows a reduction of TET3 in non-cardiomyocytes (i.e. 
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fibroblasts and endothelial cells). Interestingly, our results also demonstrate an overall 
decrease in catalytic activity of TET enzymes in general in the fibrotic hearts (Figure 
13D). 
 
                     
 
Figure 13. Mouse fibrotic hearts have decreased TET3 expression and reduced TET 
activity. 
 
(A and B) Immunohistochemistry representative images and associated graph shows the expression 
pattern of TET3 in 4 weeks of sham and angiotensin-II treated mouse hearts. Summarised quantitative 
findings are shown as mean ± SEM. (C) Relative mRNA expression of TET3 in sham and angiotensin-
II mouse fibrotic hearts. Summarised quantitative findings are shown as mean ± SD. (D) The bar graph 
shows decreased TET activity in sham and angiotensin-II mouse fibrotic hearts. Summarised 
quantitative findings are shown as mean ± SD. Statistical significance was calculated using Welch 
unpaired two tailed Student's t-test, and P-values correspond to *p ≤ 0. 05, **p ≤ 0. 01, ***p ≤ 0. 001. 
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3.5 Mouse fibrotic fibroblasts show decreased TET3 expression 
 
In mouse hearts, cardiac fibroblasts comprise around 56% of the total non-myocyte 
cell population (Zhou & Pu, 2016). Thus, we then assessed the expression of TET3 in 
cardiac fibroblasts. Expression of TET3 in fibroblasts is confirmed by co-
immunofluorescent staining with α-SMA. By counting the total percentage of TET3 
and α-SMA double-positive cells out of the total α-SMA positive cells, our results 
demonstrate that TET3 expression is significantly downregulated in angiotensin-II 
treated murine fibrotic fibroblasts as compared to sham fibroblasts (Figure 14). 
 
                      
Figure 14. Mouse fibrotic fibroblasts have decreased TET3 expression. 
 
Confocal representative images and respective graph shows double staining of TET3 and α-SMA in 4 
weeks of sham and angiotensin-II treated mouse hearts. Summarised quantitative findings are shown 
as mean ± SEM from 3 shams, and 3 Angiotensin-II treated mouse hearts. Statistical significance was 
calculated using Welch unpaired two tailed Student's t-test, and P values correspond to **p≤ 0. 01. Scale 
bars represent 10 μm. White arrow marks indicate TET3+, α-SMA+ and TET3/α-SMA++ cells at the 
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3.6 Ischemic human hearts show decreased TET3 expression  
 
Our in vivo data demonstrates downregulation of TET3 in fibrotic mouse hearts. 
Hence, our next aim was to evaluate the clinical significance of TET3 in healthy and 
diseased human hearts. Therefore, we continue examining the expression profile of 
TET3 from a publicly available microarray (GSE57345) dataset consisting of gene 
expression profile collected from healthy and diseased human hearts. The RNA 
samples analysed in the microarray were obtained from Myocardial Applied 
 Genomics Network  (MAGNet) consortium (www.med.upenn.edu/magnet/) and 
comprise information on TET3 expression in 135 ischemic left ventricles and 96 non-
failing left ventricles.   
 
Consistent with our in vivo results in mouse hearts, we also demonstrate a significant 
decrease in TET3 expression (p = .00000142) in human patient cohorts consisting of 
135 ischemic left ventricles and 96 non-failing left ventricles (Figure 15A). An 
increase in fibrosis is associated with increased COL4A1 and COL4A2 production. Our 
results demonstrate a strong negative correlation between expression of TET3 and 
COL4A1, suggesting that increased collagen production is associated with decreased 
TET3 expression (Figure 15B). Altogether, the microarray data analysed from the 
cohort of 231 human patients suggest that TET3 downregulation is associated with 




Figure 15. Ischemic human hearts have decreased TET3 expression. 
 (A) TET3 normalized signal intensity in 135 ischemic and 96 non-failing left ventricles. (B)   
Correlation graph showing negative association between TET3 and Col4a1 in 135 ischemic and 96  non-
failiing left ventricles. Pearson correlation coefficient analysis is shown as r2 in the represented graph.  
 
3.7 TET3 is positively associated with RAD51 and negatively associated 
with 53BP1 expression in ischemic human hearts 
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Recent studies have highlighted the role of TET3 in DNA damage and repair response 
(Jiang et al, 2017), and likewise, our in vivo data demonstrate an increase in DNA DSBs 
in the fibrotic mouse hearts. Therefore, TET3 may be involved in DNA repair 
responses. Consistent with this idea, we observe a strong positive correlation between 
the expression of TET3 and RAD51 (p = .0004; a marker for HR) and a negative 
correlation with 53BP1 (p = .0005; a marker for NHEJ) in the same patient cohort, 





Figure 16. TET3 is positively associated with RAD51 expression and negatively 
associated with 53BP1 expression in ischemic human hearts. 
(A) Co-relation graph showing positive association between TET3 and RAD51 in 135 ischemic and 96 
non-failing left ventricles. (B) Co-relation graph showing negative association between TET3 and 53bp1 
in 135 ischemic and 96 non-failing left ventricles. Pearson correlation coefficient analysis is shown as r2 




3.8 TET3 is recruited to the DNA DSBs in vitro in MCFs when challenged 
with H202  
 
TET3 dynamics at DNA DSB sites remain unclear. Existing studies account for H202 as 
one of the critical molecules contributing to DNA damage in hearts (Ye et al, 2016). 
Therefore, we examined the recruitment of TET3 to H202-induced DNA lesions in an 
in vitro model of mouse cardiac fibroblasts (MCFs) at 1, 2, 4, 6 and 12 hours after a 
one-time exposure to H2O2 (Figure 17A). Using γ-H2AX and TET3 co-staining, we 
demonstrated that TET3 co-localizes as distinct small foci at the sites of DNA DSBs. 
Our results show that colocalization of TET3 at DNA lesions is highest one hour after 
H202 treatment, followed by a decline. Over the course of the experiment, we observed 
that DNA damage production by H202 is discontinuous; it shows a bimodal DNA 
damage accumulation that increases twelve hours after H202 treatment (Figure 17B). 
The above results suggest that H202-induced DNA DSBs occur continuously, so using 
the present experimental setup makes it difficult to understand the dynamics of 
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recruitment of TET3 at DSBs. Therefore, we continued to search for a drug that induces 
DNA DSBs at only one time point to study the recruitment of TET3 at γ-H2AX sites. 
 
                       
 
Figure 17. TET3 is co-localized at DNA DSBs induced by H202 in vitro in MCFs. 
 
(A) Representative confocal images show TET3 (green), and γ-H2AX (red) co-localization in control 
and H202 treated MCFs. (B) The bar graph represents the number of TET3, and γ-H2AX co-localized 
foci (yellow) in H202 treated MCFs at indicative time points. For counting, 150 cells were considered 
from 3 independent experiments. Summarised quantitative findings are shown as mean ± SD. Statistical 
significance was calculated using one-way ANOVA Bonferroni and Sidak analysis, n.s. represents non-




3.9 TET3 is recruited to the DNA DSBs in vitro in MCFs when challenged 
with NCS 
 
The unsteady nature of H202-induced DNA DSBs in MCFs, which occurs because a one-
time H2O2 treatment leads to continuous endogenous H2O2 release, introduces a 
limitation to the study of recruitment of TET3 at γ-H2AX foci, so we used 
neocarzinostatin (NCS) to induce DNA DSBs. NCS has a short half-life, so a one-time 
treatment at a dose of 100 ng/ml creates a burst of DSBs that is resolved within 12 
hours (Kuo et al, 1984). Induction of DNA DSBs by NCS thus provides a method for 
the study of recruitment of TET3 at the γ-H2AX foci. Using confocal microscopy and 
double immunofluorescent staining, we found that TET3 is recruited to the DNA DSBs 
upon treatment with NCS as discrete small foci following kinetics similar to that of γ-
H2AX (Figure 18A). By counting the number of TET3 and γH2AX double-positive 
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foci, we demonstrated that recruitment of TET3 at DNA DSBs peaks after one hour of 
DNA damage and co-localized foci start to decline sharply as DNA DSBs are resolved 
(Figure 18B).  
 
                      
 
Figure 18. TET3 is co-localized at DNA DSBs induced by NCS in vitro in MCFs. 
 
(A) Representative confocal images show TET3 (green), and γ-H2AX (red) co-localization in control 
and NCS treated MCFs. (B) The bar graph represents the number of TET3 and γ-H2AX colocalized foci 
(yellow) in NCS treated MCFs at indicative time points. For counting, 150 cells were considered from 
3 independent experiments. Summarised quantitative findings are shown as mean ± SD. Statistical 
significance was calculated using one-way ANOVA Bonferroni and Sidak analysis, n.s. represents non-
significant and P-values correspond to *p ≤ 0. 05, **p ≤ 0. 01, *** p ≤ 0. 001. Scale bars represent 10 
μm.   
 
 
3.10 Proximity ligation assay confirms TET3 recruitment at DNA DSBs in 
MCFs 
 
To provide a more robust confirmation of the recruitment of TET3 at γ-H2AX sites, we 
performed proximity ligation assay (PLA). PLA is a sensitive technique used to 
visualize and study in vitro protein-protein interactions at the resolution of single cells 
(Bahjat et al, 2017). Typically, PLA uses two different primary antibodies to recognize 
the target protein-protein interactions of interest.  The two primary antibodies used in 
the experiment, therefore, must be originated from two different species. The primary 
antibodies used in the assay are then recognized with species-specific secondary 
antibodies, known as PLA plus and minus probes. Both the PLA probes are also linked 
with a short stretch of single-stranded DNA. During the experiment, when both of the 
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PLA probes are present at a distance of about 40 nM, it starts hybridizing to form a 
circular DNA in the presence of DNA ligases. Finally, upon the addition of DNA 
polymerases, these short circular DNAs are further amplified. And in the end, they are 
visualized using a fluorescent-labelled complementary oligonucleotide probe as bright 
red blobs. 
 
Based on this assay, we made use of rabbit TET3 and mouse γ-H2AX antibodies to 
confirm the recruitment of TET3 at the DSBs. As a negative control, we used no probes 
to ensure no false positive results. Previous studies have confirmed the recruitment of 
53BP1 at γ-H2AX sites using PLA (Rassoolzadeh et al, 2015). Using this information 
from the literature, we made use of rabbit 53BP1 and mouse γH2AX antibodies as 
positive controls to test our experimental setup (Figure 19A-B). In agreement with 
our confocal double staining results, these results showed increased recruitment of 
TET3 at γ-H2AX sites. These were visualized as distinct blobs after one hour of NCS 
and H202 treatment in MCFs, whereas cells without DNA damage induction produced 
no such PLA blobs (Figure 19A). 
       
 
 
Figure 19. PLA confirms the recruitment of TET3 at DNA DSBs in vitro in MCFs. 
 
(A and B) Representative images and analysis of Proximity ligation assay confirming the colocalization 
of TET3 at γ-H2AX foci upon induction of DNA damage. Negative control represents no antibody 
treatment, and positive control represents 53BP1 and γH2AX. For counting, 150 cells were considered 
from 3 independent experiments. Summarised quantitative findings are shown as mean ± SD. Statistical 
significance was calculated using one-way ANOVA Bonferroni and Sidak analysis, and P-values 
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3.11 ChIP sequencing analysis shows TET3 overlaps at DNA DSBs in 
HEK293T cells 
 
To confirm TET3 recruitment at DNA DSBs is not limited to MCFs, we analyzed ChIP-
sequencing data from publicly available database. Mining through the database, we 
found two ChIP seq data sets in HEK293 cells for TET3 and γ-H2AX. We extracted the 
processed bigwig files from the database and used easeq analysis software to overlap 
the TET3 and γ-H2AX ChIP seq peaks (GSM897577, GSE75170). Because our PLA 
results show TET3 recruits at DNA DSBs, we hypothesized we would be able to 
visualize an overlap in TET3 and γ-H2AX peaks in HEK293 cells. In agreement with 
our results in MCFs, we demonstrate a 36.97 % overlap between the TET3 and γ-H2AX 
binding sites in HEK cells (Figure 20). These results further strengthen that indeed 
TET3 gets recruited at the DNA DSBs. Moreover, the present sequencing overlaps also 














3.12 Loss of TET3 is associated with spontaneous DNA damage in MCFs  
 
Our in vitro data shows that TET3 is recruited to the DNA DSBs in healthy MCFs, 
implicating its possible role in facilitating DDR response. Therefore, to assess the role 
of TET3 in DDR, a CRISPR/Cas9-based knockdown construct was generated using two 
guide RNAs targeting exon 10 and exon 11 (Figure 21A). The guide RNA sequences 
used in the experiment were designed to have minimal off-target effects and maximum 
on-target effect. Our mRNA expression data shows that both designed guide RNAs are 
equally effective in downregulating TET3 (Figure 21B-C). However, the Western blot 
data shows that guide RNA2 targeting exon 11 is most effective in downregulating TET3 
expression (Figure 21D-E). 
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Figure 21. Establishment of TET3 knockdown in vitro in MCFs. 
 
(A) Schematic representation of CRISPR/Cas9 mediated TET3 knockdown. (B and C) Relative mRNA 
expression showing TET3 expression after TET3 knockdown by guide RNA 1 and guide RNA 2. (D and 
E) Western blot and the associated graph is representing TET3 downregulation upon targeted by guide 
RNA1 and guide RNA2. All experiments were done in triplicates. Summarised quantitative findings are 
shown as mean ± SD. For comparing between two groups, Welch unpaired two tailed Student's t-test 
was performed. For comparison between more than two groups, one-way ANOVA Bonferroni and Sidak 
analysis was performed. P-values correspond to *p ≤ 0. 05, **p ≤ 0. 01, *** p ≤ 0. 001.   
 
 
To assess the role of TET3 in DDR response, we performed TET3 knockdown in MCFs 
and examined changes in γ-H2AX foci accumulation as compared to the untreated and 
empty CRISPR/Cas9 transfected cells. Our results show that knockdown of TET3 by 
both guide RNAs causes production of endogenous DSBs. Notably, no statistically 
significant difference was observed in the generation of DSBs between guide RNA1 and 
2. But as our Western blot data shows that guide RNA2 is more effective in knocking 
down TET3, we elected to use guide RNA2 for all future experiments (Figure 21A).  
 
TET proteins share a high degree of sequence homology, so it is possible that 
knockdown of TET3 can also impact TET1 and TET2 expression. To clarify this, we 
performed mRNA expression analysis on all TET isoforms upon TET3 knockdown 
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using guide RNA2. Our results demonstrate that knockdown of TET3 does not result 
in alteration of TET1 and TET2 expression levels (Figure 22B-C). Next, we performed 
neutral comet assay using guide RNA2 to confirm the accumulation of DNA DSBs in 
MCFs. Our results demonstrate a significant increase in the tail moment (head DNA% 
× length of tail) in TET3 knockdown MCFs, confirming the presence of endogenous 
DNA DSBs (Figure 22D-E). Altogether, our results confirm that knockdown of TET3 
results in the accumulation of endogenous DNA DSBs independently of TET1 and 
TET2, as both genes remain unaltered upon TET3 knockdown.  
 
                      
 
Figure 22.  TET3 knockdown results in endogenous DNA DSBs in vitro in MCFs. 
 
(A) Representative confocal images and analysis shows increased γ-H2AX foci induction upon TET3 
knockdown. (B and C) Relative mRNA expression showing the effect of TET3 knockdown on TET1 and 
TET2 expression. (D and E) Neutral comet assay confirming the accumulation of DNA DSBs upon 
TET3 knockdown. All experiments were done in triplicates, and 150 cells were counted from 3 
independent experiments. Summarised quantitative findings are shown as mean ± SD. For comparing 
between two groups, Welch unpaired two tailed Student’s t-test was performed. For comparison between 
more than two groups, one-way ANOVA Bonferroni and Sidak analysis was performed. n.s. represents 
non-significant and P-values correspond to **p ≤ 0. 01, *** p ≤ 0. 001.    
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3.13 Knockdown of TET3 results in decreased HR but unchanged NHEJ 
efficacy in MCFs 
 
DSBs are repaired via two major pathways: the fast but error-prone non-homologous 
end-joining (NHEJ) and the slow but error-free homologous recombination (HR) 
(Iyama & Wilson, 2013). As knockdown of TET3 results in accumulation of endogenous 
DNA DSBs, we decided to assess its role in DNA DSB repair response. For this purpose, 
we made use of two DNA repair reporters: DRGFP HR (to detect HR efficiency) and 
pLCN-DSB (to detect NHEJ efficiency).   
 
DR-GFP reporter constructs consist of two differentially mutated fluorescent GFP 
genes arranged as direct repeats and separated by the presence of the puromycin 
antibiotic marker (Pierce et al, 1999). One of the mutated GFP genes harbors a 
recognition site for the rare endonuclease I-Sce1, and the other GFP gene harbors an 
internal 5′- and 3′-truncated fragment proficient at correcting the mutation in the GFP 
upon successful completion of HR.  
 
pLCN-DSB reporter constructs consist of non-functional GFP cassettes separated by a 
neomycin resistance marker (Arnoult et al, 2017). The non-functional GFP cassette 
consists of two inverted I-Sce1 sites, which upon cleavage result in functional 
restoration of the GFP signal after successful completion of NHEJ. The restored GFP 
signal using either of these reporter constructs can be measured by FACS. 
 
After using the HR and NHEJ reporter constructs in MCFs, we observed a significant 
reduction in HR repair efficiency (Figure 23A) upon knockdown of TET3, whereas 
NHEJ repair efficiency remained unaffected (Figure 23B). This result suggests that 







TET3 impacts cardiac fibrosis partially via regulation of DNA damage response  
   
  
Sandip Kumar Rath  2019  Page 50 
                      
 
Figure 23. Effect of TET3 knockdown on HR and NHEJ efficiency in vitro in MCFs. 
 
(A) MCFs integrated with a DR-GFP HR reporter substrate were transfected with TET3 knockdown 
construct and I-SceI and analyzed for change in HR efficiency by scoring % of GFP/RFP double-positive 
cells using flow cytometry. The associated graph represents HR efficacy in the ratio % of GFP/RFP 
double-positive cells. (B) MCFs integrated with a pLCN-DSB NHEJ reporter substrate were transfected 
with TET3 knockdown construct and I-SceI and analyzed for change in NHEJ efficiency by scoring % of 
GFP/RFP double-positive cells using flow cytometry. RFP was used in all the experiments to ensure 
transfection efficiency. All experiments were done in triplicates. Summarised quantitative findings are 
shown as mean ± SD. Statistical significance was calculated using Welch unpaired two tailed Student's 
t-test, n.s. represents non-significant and P-values correspond to **p ≤ 0. 01.   
 
 
3.14 Knockdown of TET3 results in decreased DNA end resection in MCFs 
 
The readout from our reporter constructs demonstrates that TET3 knockdown MCFs 
have decreased HR efficacy. Diminished HR efficacy can result from either in-efficient 
DNA end resection or an improper resolution of D-loops by DNA resolvases 
(Kakarougkas & Jeggo, 2014). Inappropriate resolution of D-loops leads to genomic 
instability, increased anaphasic bridges, and micronuclei formation (Daley et al, 2014; 
Falquet & Rass, 2017). As in our results no such abnormal features were observed upon 
TET3 knockdown, we hypothesized that decreased DNA end resection could be the 
prime factor contributing to reduced HR efficiency. So, to understand whether the 
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observed decreased HR efficacy is due to limited or diminished DNA end resection, we 
performed a bromodeoxyuridine (BrdU)-based pulse chase assay. BrdU is a thymine 
analogue, which under DNA denaturing conditions incorporates into the single-
stranded DNA (ssDNA) actively generated during DNA end resection (Mukherjee et al, 
2015). While BrdU incorporation under physiological condition reflects cell 
proliferation (as traditional assays rely on DNA replication to allow BrdU to get 
integrated into the DNA), under denaturing conditions, BrdU incorporation is 
associated with DNA end resection because denaturation halts and dissociates DNA 
replication machinery, and hence, BrdU can only get incorporated if ssDNA is 
available. Using anti-BrdU antibodies, the overall change in fluorescence intensity of 
BrdU incorporation can be measured. A change in BrdU incorporation, thus, serves as 
a direct readout for DNA end resection (Mukherjee et al, 2015). 
 
To test this concept, we first established that our TET3 rescue experiment is working. 
Briefly, 2 days after TET3 knockdown, we again re-transfected MCFs with 2.5 μg of 
TET3 overexpression plasmid. The knockdown cells rescued with TET3 overexpression 
construct are then left for 36 hours to recover. After 36 hours of recovery, the cells are 
collected and immediately processed for collecting the total protein lysate. 
Immunoblot analysis using 50 μg of protein illustrate that the knockdown and rescue 
experiment worked in the present experimental setup. Image J quantification of the 
blots clearly show an increase in TET3 protein expression upon rescue with over 
expression construct. Moreover, in the present experimental setup we are able to 
demonstrate a constant decrease in TET3 expression upon knockdown, showing 
robustness of our Crispr/Cas9 targeted TET3 knockdown construct. We then 
continued to assess the planned DNA end resection study using BrdU assay and our 
results show that TET3 knockdown in MCFs causes a decrease in BrdU fluorescence 
intensity that can be partly rescued upon re-expression of TET3. Decreased BrdU 
incorporation thus reflects a decrease in DNA end resection mechanism in TET3 
knockdown MCFs (Figure 24). 
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Figure 24. TET3 knockdown results in decreased BrdU incorporation in vitro in MCFs.  
(A) Western blot and the associated graph are representing TET3 downregulation and overexpression 
in MCFs. (B) The bar graph represents decrease in BrdU incorporation due to inefficient DNA end 
resection. All experiments were done in triplicates. Summarised quantitative findings are shown as 
mean ± SD. Statistical significance was calculated using Welch unpaired two tailed Student's t-test, n.s. 
represents non-significant and P-values correspond to *p ≤ 0. 05, **p ≤ 0. 01, *** p ≤ 0. 001.  
 
 
3.15 Knockdown of TET3 results in impaired recruitment of RAD51 to 
DNA DSBs in MCFs 
 
To gain further insight into the role of TET3 in DNA end resection, we continued to 
study the recruitment of RAD51 at the DNA DSBs in TET3 knockdown and rescued 
MCFs. RAD51 is an essential monomeric protein complex, which binds to the end of 
resected single-stranded DNA tails and facilitates sister chromatid strand invasion 
(Ivanov et al, 2003; Sullivan & Bernstein, 2018). Previous studies have shown that 
RAD51 is recruited to sites of DNA damage when regions of ssDNA are exposed (Ma et 
al, 2017; Špírek et al, 2018). Hence, it serves as a direct readout for understanding the 
ongoing DNA end resection during HR. To confirm this, we performed staining for γ-
H2AX in combination with RAD51 upon TET3 knockdown or rescue in NCS-treated 
MCFs. Our data demonstrate that upon NCS-induced DNA damage, RAD51 recruits to 
DSBs (Figure 25A). Interestingly, our results show that TET3 knockdown in MCFs 
results in increased RAD51 expression. Unlike in control MCFs, however, the 
recruitment of RAD51 to DNA DSBs is severely reduced in TET3 knockdown cells, 
despite an increase in DNA DSBs. Moreover, this effect continues to persist in TET3 
knockdown MCFs challenged with NCS. These results suggest that although RAD51 
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expression is elevated, its recruitment to DSBs foci continues to get affected in the 
absence of TET3 and increased DSBs. Notably, this effect is reversed upon the rescue 
of TET3 expression, confirming the absence of TET3 indeed is the reason for the 
observed improper RAD51 recruitment. Additionally, impaired recruitment of RAD51 
to the DNA DSBs in TET3 knockdown MCFs confirms our hypothesis and previous 
result of decreased DNA end resection (Figure 24B).  
 
                      
 
Figure 25. TET3 knockdown results in impaired recruitment of RAD51 at DNA DSBs in 
vitro in MCFs.  
 
(A and B) Representative confocal images and an associated histogram shows rad51 (green) and γ-
H2AX (red) co-localization (yellow) in MCFs in control, TET3 knockdown, and rescued cells (n=100 
cells were analyzed in each condition from 3 different experiments). Summarised quantitative findings 
are shown as mean ± SD. Statistical significance was calculated using one-way ANOVA Bonferroni and 
Sidak analysis, n.s. represents non-significant and P-values correspond to *p ≤ 0. 05, **p ≤ 0. 01, *** p 
≤ 0. 001.   
 
 
3.16 Knockdown of TET3 results in unchanged recruitment of 53BP1 to 
DNA DSBs in MCFs 
 
Using our NHEJ reporter constructs, we previously confirmed that the loss of TET3 
does not result in a change in NHEJ efficacy. In line with this observation, we 
investigated the recruitment of 53BP1 (a core NHEJ repair protein) at the DNA DSBs 
in control, TET3 knockdown and rescued NCS-treated MCFs. In agreement with the 
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results from our reporter constructs, we observed no significant change in 53BP1 foci 
at DNA DSBs in TET3 knockdown and rescued MCFs, suggesting that TET3 is involved 
only in the HR-mediated DDR response. Notably, although NHEJ is operational in 
TET3 knockdown MCFs, our data illustrates DNA DSBs is not resolved completely. We 
hypothesized there could be two possible reasons for such discrepancy. First, since the 
amount of DSBs is higher in TET3 knockdown MCFs even in absence of exogenous 
DNA damage causing agents, these cells just take longer time to repair. Second, the 
DSBs produced in cardiac fibroblasts in absence of TET3 could have more 
incompatible DNA ends, hence simple re-ligation of these broken ends is not feasible 
by NHEJ. This idea is well supported by the recent finding by Chang et.al, where they 
illustrate the importance of DNA DSBs ends in limiting the chances of NHEJ mediated 
DDR response (Chang et al, 2016). (Figure 26A-B).  
 
                      
 
Figure 26.  TET3 knockdown does not affect the recruitment of 53bp1 at DNA DSBs in 
vitro in MCFs. 
(A and B) Representative confocal images and an associated histogram shows 53bp1 (green) and γ-
H2AX (red) colocalization (yellow) in MCFs in control, TET3 knockdown, and rescued cells (n=100 
cells were analyzed in each condition from 3 different experiments). Summarised quantitative findings 
are shown as mean ± SD. Statistical significance was calculated using one-way ANOVA Bonferroni and 
Sidak analysis, n.s. represents non-significant and P-values correspond to *p ≤ 0. 05, **p ≤ 0. 01, *** p 
≤ 0. 001.   
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3.17 Knockdown of TET3 results in decreased global chromatin 
accessibility 
 
Compaction and decompaction of chromatin play a key role in facilitating DDR 
response (Burgess et al, 2014; Hauer & Gasser, 2017). Recent investigations 
demonstrate that compacted chromatin causes efficient activation of the upstream 
DDR signalling (ATM/ATR) kinases but not its downstream components (Burgess et 
al, 2014). This establishes that a compacted chromatin state can result in an attenuated 
DDR response in cells. Additionally, studies have also linked the state of chromatin to 
the facilitation of the correct choice of DNA repair (Lemaitre et al, 2014; Stadler & 
Richly, 2017). Studies demonstrate that chromatin compaction restricts the mobility 
of the HR repair by disturbing nucleosome eviction during active DNA end resection 
and strand invasion (Oliveira et al, 2014; Yang et al, 2013). Additionally, studies 
suggest that DNA damage in compacted chromatin is favorably repaired by NHEJ 
(Noon et al, 2010), as this repair response operates via simple re-ligation of the broken 
ends.  
 
Previous studies have shown that compacted chromatin limits the efficacy of HR  
(Sonoda et al, 2006). In line with these observations, our previous data have shown 
that loss of TET3 results in decreased HR efficacy in MCFs due to impaired DNA end 
resection and improper loading of RAD51 to the DNA DSBs. So, we hypothesized that 
this effect in TET3 knockdown cells could be a result of chromatin compaction.  
 
To test this hypothesis, we used DAPI staining, which allows to analyse the intensity 
distribution within the nucleus as a measure of compaction using confocal microscopy 
(Figure 27A). Our results show that TET3-deficient MCFs have more compacted 
chromatin than healthy MCFs. Additionally, by re-expressing TET3 in the knockdown 
MCFs, we can relax the chromatin to be comparable to healthy MCFs (Figure 27B). 
This data demonstrates that the loss of TET3 results in compaction of chromatin which 
may then contribute to limiting HR efficacy. 
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Figure 27. TET3 knockdown results in chromatin compaction in vitro in MCFs. 
        
(A and B) DAPI intensity distribution and representation analyzed by confocal microscopy in Control, 
TET3 knockdown and rescued cells.  
 
 
3.18 TGF-β treatment results in decreased TET3 expression but increased 
proliferation in MCFs 
 
TGF-β is a highly pleiotropic cytokine that is widely known to induce fibroblast 
proliferation. Studies in murine keratinocytes and human epidermoid carcinoma cells 
have shown the involvement of TGF-β in the maintenance of genomic stability and 
DDR responses (Kim et al, 2015; Lee et al, 2016). In line with these observations, it is 
plausible that TGF-β could promote the proliferation of fibrotic fibroblasts by resolving 
the DNA damage. Our results demonstrate that TET3 deficient fibroblasts proliferate 
at a slower rate and have endogenous DNA damage. Thus, we hypothesised that TGF-
β might be involved in resolving the DNA DSBs, helping TET3-deficient fibroblasts 
proliferate.  
 
In order to test the role of TGF-β in promoting proliferation, we treated MCFs with 15 
ng/mL of TGF-β and counted the cell doubling rate as well proliferation on every 
alternate day for ten days. Our results show that TGF-β caused both rapid increase in 
cell number and proliferation. However, upon removal of TGF-β on day five, we 
observed both decrease in cell number as well as proliferation. Altogether, our results 
show that exposure to TGF-β results in increased cell proliferation which then 
decreases upon removal of TGF-β after 5 days (Figure 28A-B). 
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Having confirmed that TGF-β promotes cell proliferation, we then assessed whether it 
facilitates resolving DNA DSBs. To address this, we performed γ-H2AX staining on 
every alternate day for ten days in MCFs. Interestingly, our results show that exposure 
to TGF-β for 5 days results in the formation of DNA DSBs (Figure 28C-D). Moreover, 
upon removal of TGF-β, we observed increased accumulation of DNA DSBs (Figure 
28C-D). From these results, it can be understood that the presence of TGF-β helps in 
resolving DNA damage which helps the cells to proliferate. Removal of TGF-β on day 5 
fails to resolve the DNA damage, which in turn results in decreased cell proliferation.   
 
Our in vivo data demonstrates that fibrotic fibroblasts have decreased TET3 
expression. We attempted to mimic the fibrotic state in MCFs upon TGF-β treatment 
and predicted that prolonged exposure would result in decreased TET3 expression. 
From our TET3 fluorescence staining and mRNA expression analysis, we confirmed 
downregulation of TET3 upon TGF-β treatment in MCFs. Moreover, upon removal of 
TGF-β on day 5, expression of TET3 remained downregulated (Figure 28E).  
 
Recent studies also demonstrate that TGF-β can drive changes in epigenetic writers. 
While we cannot exclude that even longer exposure to TGF-ß also leads to persistently 
increased proliferation, we suspect that the observed decrease in TET3 expression 
could be a result of the change in epigenetic balance at either the methylation or histone 
modification level.  
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Figure 28. TGF-β treatment in MCFs affects cell count, proliferation, DNA damage and 
TET3 expression. 
 
(A) The representative graph shows the effect of TGF-β on cell number in MCFs at indicative days. 
(B) The representative graph shows relative cell proliferation in control and TGF-β treated MCFs at 
indicative days. Summarised quantitative findings are shown as mean ± SD. (C and D) 
Representative confocal images and the associated graph shows the effect of TGF-β on γ-H2AX and 
TET3 expression in MCFs at indicative days. Summarised quantitative findings are shown as mean ± 
SEM. (E) Relative TET3 mRNA expression upon TGF-β treatment in MCFs at indicative days. 
Summarised quantitative findings are shown as mean ± SD. All the represented experiments are done 
in triplicates, and statistical significance was calculated using one-way ANOVA Bonferroni and Sidak 
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3.19 TGF-β treatment results in decreased DSBs in MCFs 
 
Next, we continued to investigate how cardiac fibroblasts manage to proliferate during 
fibrosis despite the presence of DNA damage. To understand this, we mimicked fibrotic 
conditions by treating NCS treated MCFs and TET3 knockdown MCFs with TGF-β 
(Figure 29A).  Consistent with previous studies, by counting the number of γ-H2AX 
foci per nucleus, we observed that pre-treatment with TGF-β in MCFs exposed to NCS 
(both under wildtype and TET3 knockdown conditions), leads to a decreased 
accumulation of DNA DSBs after 1 hour, which continuously declines further until 12 
hours after NCS exposure (Figure 29B-C).  
 
                    
 
Figure 29. TGF-β decreases DNA DSBs in MCFs. 
 
(A, B and C) Representative confocal images and an associated histogram is showing DNA damage 
recovery analyzed by resolving of γ-H2AX (red) in the presence or absence of TGF-β at indicated 
conditions (n=100 cells were analyzed in each condition from 3 different experiments). Summarised 
quantitative findings are shown as mean ± SD. Statistical significance was calculated using Welch 
unpaired two tailed Student's t-test, n.s. represents non-significant and P-values correspond to *p ≤ 0. 
05, **p ≤ 0. 01, *** p ≤ 0. 001.   
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3.20 TGF-β treatment activates increased NHEJ repair 
 
Our previous data show that TGF-β pre-treatment results in decreased γ-H2AX foci 
(both in control and in TET3 knockdown MCFs), even when challenged with exogenous 
DNA DSBs inducing drug NCS. This suggests the possibility that treatment with TGF-
β in MCFs either limits sensing of DNA DSBs or improves DNA repair capacity. To 
clarify this, we continued to use the HR and NHEJ DNA repair constructs and analysed 
the effect on DNA repair efficacies in the presence or absence of TGF-β in control and 
TET3 knockdown MCFs. Our results show that pre-treatment of TGF-β over 24 hours 
results in a marked decrease in HR efficiency when analysed by the presence of the 
percentage of GFP and RFP double-positive cells by FACS (Figure 30A). This result 
is in line with a previously published study in CD44+/CD24−cancer cells in which 
TGF-β signalling was reported to decrease HR efficacy (Pal et al, 2017). We reported 
that TGF-β also downregulates TET3 expression, which is involved in the HR repair. 
In line with these observations, our results show that TGF-β, in combination with 
reduced TET3 expression also shows a decreased HR efficiency (Figure 30A-B). 
However, we noticed that the combination of TGF-β and TET3 knockdown does not 
show an additive decrease in HR efficacy but instead is maintained at more or less the 
same levels, (Figure 30A), which is likely due to the fact that TGF-ß treatment per se 
leads to decreased expression of TET3 as previously shown.  
 
After having established that TGF-β downregulates HR efficacy, we continued to 
investigate whether an increase in NHEJ results in improved DNA repair capacity. 
Using NHEJ reporter construct analysis, we demonstrate that indeed TGF-β 
upregulates NHEJ repair efficiency and this increase is maintained in TET3 
knockdown cells treated in combination with TGF-β (Figure 30C-D). From these 
results, we conclude that the decrease in DSBs observed upon TGF-β treatment in 
MCFs is a result of enhanced NHEJ repair efficiency.  
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Figure 30. TGF-β increases NHEJ mediated DNA repair response in MCFs. 
 
(A and B) MCFs integrated with a DR-GFP HR reporter substrate were transfected in indicated 
conditions in combination with I-Sce-1 and analyzed for change in HR efficiency by scoring % of 
GFP/RFP double-positive cells using flow cytometry. (C and D) MCFs integrated with a pLCN-DSB 
NHEJ reporter substrate were transfected in indicated conditions in combination with I-Sce-1 and 
analyzed for change in NHEJ efficiency by scoring % of GFP/RFP double-positive cells using flow 
cytometry. RFP was used in all the experiments to ensure transfection efficiency. All experiments were 
done in triplicates. Summarised quantitative findings are shown as mean ± SD. Statistical significance 
was calculated using Welch unpaired two tailed Student's t-test, n.s. represents non-significant and P-
values correspond to *p ≤ 0. 05, **p ≤ 0. 01, *** p ≤ 0. 001.  
 
 
3.21 TGF- β treatment promotes proliferation in cardiac fibroblasts 
which can be rescued by TET3 overexpression 
 
Our previous results demonstrate that TGF-β treatment results in decreased TET3 
expression and an increased number of cells and proliferation. Additionally, our results 
show that TGF-β increases NHEJ efficacy and that the loss of TET3 decreases HR 
efficacy. Furthermore, existing studies in the literature demonstrate that the activation 
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of HR requires the engagement of the G2M phase arrest. Thus, we hypothesized that 
overexpression of TET3 in TGF-β treated fibroblasts would result in decreased cell 
proliferation due to the activation of the checkpoint arrest-assisted HR-mediated DNA 
repair. Moreover, as TGF-β treatment per se results in decreased TET3 expression, 
hence, we also hypothesized that the cell proliferation rate would be unchanged in 
TGF-β treated MCFs with or without CRISPR mediated TET3 knockdown.  
  
To examine our hypothesis, as previously described, we used TGF-β to mimic a fibrotic 
environment and then compared the change in the number of cells and proliferation 
over 7 days between TET3 knockdown MCFs combined with TGF-β, with the change 
in the number of cells and proliferation in TGF-β-treated MCFs. Our cell counting and 
proliferation results show that TET3 knockdown MCFs treated with TGF-β show no 
significant change in cell numbers and the proliferation rate compared to the TGF-β-
treated MCFs (Figure 31A-B).  
 
However, TGF-β-treated MCFs and TET3 knockdown MCFs treated with TGF-β show 
an increased proliferation rate compared to the control MCFs (Figure 31B). Notably, 
our previous results also demonstrate that NHEJ repair efficiency is maintained at a 
steady state in TGF-β treated MCFs and TET3 knockdown cells treated in combination 
with TGF-β. These results demonstrate that the loss of TET3 has no additive effect on 
the change in cell number and proliferation state in TGF-β-treated MCFs.  
 
Next, we continued investigating our hypothesis that TET3 overexpression in TGF-β-
treated MCFs should likely result in decreased cell proliferation. As expected, our 
results show that the re-expression of TET3 in fibrotic conditions restrains not only 
cell numbers but also proliferation (Figure 31). Existing studies demonstrate that 
increased DNA end resection due to HR leads to apoptosis in proliferating cells (van 
den Berg et al, 2019). Therefore, it is highly likely that an increase in TET3 expression 
in proliferating TGF-β-treated MCFs results in a decrease in the cell number due to 
additionally increased apoptosis induced by DNA end resection.   
 
So far, from our results, we confirm that TET3 overexpression leads to a decrease in 
cell proliferation in TGF-β-treated MCFs. Moreover, our data also suggests that cell 
proliferation is, in part, regulated by the choice of engaged DNA repair. Thus, we 
continued investigating whether this restrained cell proliferation observed upon TET3 
overexpression, as per our hypothesis is, in part, a consequence of increased HR-
mediated repair in proliferating MCFs. As, proper engagement of HR requires 
activation of cell cycle checkpoints, we decided to first look into the H3s10p status and 
later on into the change in DNA repair efficacies.   
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Figure 31. TGF-β dramatically increases proliferation rate in MCFs which can be 
rescued by TET3 overexpression. 
 
(A) The representative graph shows the effect of TGF-β on cell number in control, TET3 knockdown, 
and overexpressed MCFs over 7 days. (B) The representative graph shows the effect on cell proliferation 
in MCFs pre-treated with TGF-β in control, TET3 knockdown, and overexpressed cells. Summarised 
quantitative findings are shown as mean ± SD. All experiments were done in triplicates, and statistical 
significance was calculated using one-way ANOVA analysis, n.s. represents non-significant and P-values 
correspond to *p ≤ 0. 05, **p ≤ 0. 01, *** p ≤ 0. 001. 
 
 
3.22 TGF- β treatment results in increased H3s10p in MCFs 
 
Phosphorylation of histone at serine 10 is a sensitive marker for detecting cells 
committed to the mitotic phase (Hans & Dimitrov, 2001); (Dong & Bode, 2006). 
Studies have shown that an increase in the H3s10p signal characterizes a cell’s 
commitment to proliferate. Moreover, H3s10p provides a positive feedback signal for 
the clearance from checkpoint activation and thus prepares the cells to engage through 
anaphase and undergo proliferation (Monier et al, 2007). Therefore, as per the 
literature, a decrease in H3s10p indicates the activation of the G2/M checkpoint, while 
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an increase in H3s10p indicates clearance of G2M arrest and commitment to 
proliferation. 
 
In line with these observations, studies have also shown that the presence of DSBs 
results in decreased H3s10p activation (Hilmi et al, 2017), which allows proper 
engagement of HR-mediated DNA repair. Based on our previously observed cell 
proliferation data, we next continued by assessing the activation of H3s10p in the 
control and TGF-β treated MCFs.  
 
Our results demonstrate that, upon induction of DNA DSBs, MCFs activate the proper 
G2/M arrest marked by a decreased H3s10p activation (Figure 32A-B). This result 
suggests that, in healthy fibroblasts, the commitment to proliferation is affected by the 
presence of DSBs due to the efficient activation of HR. 
 
Interestingly, in our previous data, we observed that TGF-β treatment in MCFs results 
in decreased DNA DSBs via increased NHEJ. As per previous studies, it is well known 
that the engagement of NHEJ does not require the cells to be arrested in the G2M 
phase. Thus, we expected TGF-β-treated MCFs to have increased H3s10p status. 
Indeed, our results show that MCFs treated with TGF-β have increased H3s10p 
(Figure 32C-D), suggesting increased commitment to cell proliferation. This result 
agrees with our results of increased cell proliferation in TGF-β-treated MCFs, 
compared to untreated MCFs. 
 
However, we noticed that the combination of TGF-β and TET3 knockdown does not 
show an additive increase in H3s10p but instead is maintained at more or less the same 
levels, (Figure 32C-D), which is likely because TGF-ß treatment per se leads to 
decreased TET3 expression. These results agree with the cell proliferation data, 
wherein we reported that the loss of TET3 has no additive effect on the proliferation of 
TGF-β-treated MCFs.  
 
However, in the present study, we observed that TET3 facilitates HR-mediated DNA 
repair, which requires the G2M checkpoint arrest to operate. Notably, from our 
previous data, we confirmed that overexpression of TET3 results in restraining the cell 
proliferation in TGF-β-treated MCFs. In line with these observations, we hypothesized 
that the overexpression of TET3 in TGF-β-treated MCFs could result in decreased 
H3s10p due to increased G2M arrest favoring HR-mediated DNA repair. Indeed, our 
results demonstrate that, upon re-expression of TET3, TGF-β-treated MCFs 
dramatically reduce H3s10p (Figure 32E-F), suggesting the activation of HR.  
 
Altogether, our results suggest that the restraint in cell proliferation upon TET3 
overexpression in TGF-β-treated MCFs may be, in part, a consequence of the activation 
of a slow G2M checkpoint-dependent HR. So, we continued by assessing the change in 
HR repair efficacy, to test if indeed the decreased cell proliferation is partly a 
consequence of TET3 mediated shift in DNA repair.  
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Figure 32. TGF-β increases H3s10p signalling in vitro in MCFs. 
(A-F) Flow cytometry analysis of histone H3 on Ser-10 (pH3) representing the mitotic index in Control, 
NCS, TGF-β or TGF-β with either TET3 knockdown or TET3 overexpressed MCFs at indicated time 
points (n=10,000 cells analyzed in each condition from 3 different experiments. Summarised 
quantitative findings are shown as mean ± SD. All experiments were done in triplicates. Statistical 
significance was calculated using either unpaired nonparametric two-tailed student t-test or one-way 
ANOVA Bonferroni and Sidak analysis, n.s. represents non-significant and P-values correspond to * p ≤ 
0. 05, ** p ≤ 0. 01, and *** P ≤ 0. 001.    
 
 
3.23 TET3 overexpression in TGF- β treated MCFs results in an increased 
HR repair 
 
The results from our cell proliferation data indicate that overexpression of TET3 causes 
decreased cell proliferation in TGF-β-treated MCFs. As TET3 is involved in the HR-
mediated DNA repair response, we hypothesized that the observed restraint in the 
increase in cell numbers and proliferation can be associated with an increased HR. To 
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understand this idea, we again used HR repair reporter constructs and checked the 
change in HR efficacy in the TET3 overexpressed condition. Analyzing the percentage 
of GFP and RFP double-positive cells by FACS, we demonstrated an increase in HR 
efficiency on TET3 overexpression in TGF-β-treated MCFs (Figure 33). Studies have 
shown that an increased HR repair response provides negative feedback to cell 
proliferation (Yoon et al, 2014). Consistent with these studies, our results demonstrate 
an increase in HR upon TET3 overexpression, likely restraining cell proliferation. 
Surprisingly, our results demonstrate that TET3 overexpression in TGF-β-treated 
MCFs also results in decreased NHEJ.  A recent study shows that increased DNA end 
resection or hyper-recombination events due to HR lead to a decreased NHEJ-
mediated DNA repair efficacy (Lopez-Saavedra et al, 2016). Our present results are in 
line with these studies and show that the balance of DNA repair is crucial for the cell 
survival. Thus, from the observed results, we demonstrate that presence of TET3 
indeed has an effect on cell proliferation in fibrotic fibroblasts, partly via regulating the 
choice of DNA repair. 
 
                          
 
Figure 33. TET3 overexpression results in increased HR repair efficacy in TGF-β treated 
MCFs. 
 
(A and B) DNA repair constructs showing HR and NHEJ repair efficiency in TGF-β pre-treated MCFs 
with or without TET3 overexpression conditions (n=10,000 cells analyzed in each condition). RFP was 
used in all the experiments to ensure transfection efficiency. All experiments were done in triplicates. 
Summarised quantitative findings are shown as mean ± SD. Statistical testing was done using Welch 
unpaired two tailed Student's t-test. Significant P-values are represented in the graphs **p ≤ 0. 01.  
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3.24 Mouse fibrotic fibroblasts have increased NHEJ mediated repair in 
in vivo 
 
Thus far, we conclude that the loss of TET3 results in TGF-β-treated MCFs favoring 
NHEJ-mediated DNA repair, which in turn provides a proliferative advantage to the 
TGF-β-treated MCFs. In line with these findings, we want to establish that our in vitro 
results can be recapitulated in our in vivo mouse fibrotic model. Therefore, to evaluate 
the significance of our observed in vitro results, we continued to assess the expression 
of 53bp1 (a core NHEJ repair factor) in the fibrotic fibroblasts of our angiotensin-II-
treated mouse hearts. Using 53bp1 and α-SMA double immunofluorescent staining, we 
confirmed increased 53bp1 expression in fibrotic fibroblasts of our angiotensin-II-
treated mouse hearts, suggesting increased NHEJ repair (Figure 34). Previously, our 
in vivo results demonstrated increased expression of Ki67 in fibrotic fibroblasts. In line 
with all of these observations, our results altogether demonstrate that the loss of TET3 
favors increased NHEJ repair response in fibrotic fibroblasts to provide a proliferative 
advantage in an abundant DNA damage niche.  
 
                      
Figure 34.  Mouse fibrotic fibroblasts have increased 53bp1 expression in vivo. 
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(A and B) Confocal representative images and the respective graph shows double staining of 53bp1 and 
α-SMA in 4 weeks of sham and angiotensin-II treated mouse hearts. The arrow marks represent the 
fibroblasts positive or negative for 53bp1 in 4 weeks of sham and angiotensin-II treated mouse hearts. 
Summarised quantitative findings are shown as mean ± SEM from 3 shams, and 3 Angiotensin-II treated 
mouse hearts. Statistical significance was calculated using Welch unpaired two tailed Student's t-test, 
and P-values correspond to **p≤ 0. 01. Scale bars represent 10 μm. 
 
 
3.25 Human fibrotic hearts lose TET3 expression  
 
Our in vitro and in vivo data in mouse cardiac fibroblasts show that the expression of 
TET3 is downregulated during fibrosis. Additionally, the microarray data of ischemic 
human hearts also demonstrated a significant decrease in TET3 expression. Therefore, 
to evaluate the clinical significance of the proposed study during cardiac fibrosis in 
human patients, we continued by assessing the expression pattern of TET3 in 
fibroblasts of non-fibrotic and fibrotic human heart biopsies obtained from patients 
with aortic stenosis. Masson’s trichome staining was performed to confirm and 
quantify the fibrosis in human hearts (Figure 35A-B). Next, using hematoxylin/eosin 
(H&E) staining, we confirmed the change in morphology of fibrotic and non-fibrotic 
human hearts (Figure 35A). The expression of TET3 in fibroblasts is confirmed by 
co-immunofluorescent staining with α-SMA (Figure 35C). By counting the total 
percentage of TET3 and α-SMA double-positive cells out of the total α-SMA positive 
cells, we demonstrate that TET3 expression is downregulated in fibroblasts of fibrotic 
human hearts (Figure 35D), suggesting TET3 plays a role in the maintenance of low 
fibroblast numbers in healthy human hearts. 
                
 
Figure 35. Human fibrotic fibroblasts have decreased TET3 expression. 
           
(A) MTS and H&E staining in non-fibrotic and fibrotic human hearts. (B) Graph representing % of the 
fibrotic area in non-fibrotic and fibrotic human hearts. (C and D) Confocal representative images and 
the respective graph shows double staining of TET3 and α-SMA in non-fibrotic and fibrotic human 
hearts. Arrows mark fibroblasts positive for TET3 in non-fibrotic and fibrotic human hearts. 
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Summarised quantitative findings are shown as mean ± SEM. Statistical significance was calculated 
using Welch unpaired two tailed Student's t-test, and P-values correspond to *p≤ 0. 05. Scale bars 





Activation and proliferation of cardiac fibroblasts are the prime mediators of cardiac 
fibrosis (Khalil et al, 2017). Existing studies indicate that ROS and inflammatory 
cytokines produced during fibrogenesis not only result in increased proliferative 
stimuli but also contribute to DNA damage in the form of DSBs (Cheng et al, 2003; 
Cucoranu et al, 2005; Weyemi et al, 2015). The presence of DSBs normally halts the 
cell cycle and activates DNA repair machinery to resolve the damage (Delacote & 
Lopez, 2008). However, in pathological conditions, such as fibrosis, there is a 
continuous need for activation and proliferation. Therefore, to maintain a sustained 
proliferation of cardiac fibroblasts, the activation of a distinct DNA repair mechanism 
is essential. Previous studies from our lab have highlighted the protective role of TET3, 
a DNA demethylase enzyme in organ fibrosis (Tampe et al, 2014; Xu et al, 2015; Xu et 
al, 2018). Notably, emerging studies have linked the role of TET3 to DDR response. In 
line with these observations, the entire work of my dissertation is focused on 
understanding (a) the expression of TET3 and DNA damage in cardiac fibrosis (b) the 
role of TET3 in dictating the DNA repair pathway choice, and (c) whether TET3 has a 
role in facilitating proliferation of the fibroblasts in the fibrotic niche via modulation 
of DNA damage and repair response. 
 
Thus far, we have demonstrated that TET3 affects DNA damage response mechanisms 
via orchestrating checkpoint-assisted homologous recombination-mediated DDR and 
that TGF-ß, in combination with the lack of TET3 in cardiac fibrosis, leads to a shift 
from HR-mediated DNA damage response to a checkpoint-independent non-
homologous end-joining DDR (Figure 33). Using γ-H2AX and TET3 staining, we 
demonstrate DNA DSB accumulation and a reduction of TET3 expression in fibrotic 
fibroblasts in the angiotensin-II mouse model of cardiac fibrosis (Figure 11 and 
Figure 14). The DNA repair kinetics in vitro in MCFs revealed that, when challenged 
with DNA damage, TET3 is recruited to the γH2AX foci. Recruitment of TET3 to the 
DSBs was confirmed using high definition laser confocal microscopy and a sensitive 
PLA assay in vitro in MCFs (Figure 17, Figure 18 and Figure 19). By using DNA 
repair reporter constructs for HR and NHEJ, respectively, we further confirmed that 
TET3 mediates the error-free, but checkpoint-assisted slower HR to repair DNA DSBs 
in MCFs (Figure 23). Additionally, using CRISPR/Cas9-based knockdown in MCFs, 
we demonstrate that the loss of TET3 results in the compaction of chromatin and the 
production of endogenous DSBs in the absence of any external damage stimuli 
(Figure 22 and Figure 27). Notably, we also demonstrated that the decreased HR 
efficacy in TET3 knockdown MCFs is a result of diminished DNA end resection 
(Figure 24). The most interesting aspect of the entire study is that, upon pre-
treatment with TGF-β in MCFs, we demonstrate that loss of TET3 is accompanied by 
a switch to NHEJ-based DDR, faster clearance of DNA damage, re-entry into the cell 
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cycle, and increased proliferation, which can be rescued by overexpression of TET3 
(Figure 31 and Figure 33).  




Figure 36. Schematic representation illustrating the role of TET3 in modulating the 
DDR response in healthy and fibrotic fibroblasts. 
 
 
4.1 TET3 affects DNA damage and repair in cardiac fibroblasts 
 
Studies are highlighting the role of DNA demethylases as a new independent factor in 
orchestrating the DNA damage and repair responses (Wu & Zhang, 2017). In line with 
these observations, a recent study has shown that  TET3 plays a key role in efficient 
repair of DNA lesions, thereby providing protection against genomic instability in 
mouse embryonic fibroblasts (Jiang et al, 2017). However, it is not quite clear from 
these studies whether TET3 could be involved in the repair of DNA DSBs or whether 
TET3 is actually recruited to the DNA DSBs.  
 
If TET3 recruits to DNA DSBs, does it have an influence on the two most common DSB 
repair pathways, HR and NHEJ? In the present study, using confocal imaging and the 
PLA assay, we demonstrated that TET3 is recruited to the DNA DSBs. In addition, 
using readouts from the DNA repair reporter constructs, we showed that TET3 
facilitates HR-mediated but not NHEJ-mediated DNA repair (Figure 23). To our 
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knowledge in the context of cardiac fibroblasts, this is the first study to demonstrate 
that TET3 is recruited at the DNA DSBs and mediates the choice for HR-mediated DNA 
repair. In the context of cardiac fibroblasts, these findings open interesting research 
avenues on the role of TET3 in DNA DSB repair responses. 
 
As per the literature, post-translational modifications of the proteins are crucial for 
their involvement in DSB repair (Polo & Jackson, 2011). This idea is in line with a 
previously published study in glial and MEFs cells in which ATM and ATR kinase were 
reported to phosphorylate TET1 and TET3 to stabilize their expression during DNA 
damage (Jiang et al, 2017; Jiang et al, 2015). Mass-spectrometry studies in HEK293 
cells show that the N-terminal domain of TET3 is highly subjected to post-translational 
modifications (Bauer et al, 2015). In the same study, it was also reported that the 
phosphorylation serine-362 position competes with oGlcNAcylation, the outcome of 
which dictates TET3 nuclear retention (Bauer et al, 2015). This report is well supported 
by a previous study on Hela cells, where oGlcNAcylation of TET3 is shown to promote 
cytoplasmic export (Zhang et al, 2014). In line with these results, it would be 
noteworthy to precisely explore the phosphorylation status of TET3 because it could 
explain whether post-translational phosphorylation is indispensable for the 
recruitment of TET3 to the γ-H2AX foci.  
 
The TET proteins are best known for their role in DNA hydroxymethylation (Tahiliani 
et al, 2009). The existing studies in MEFs demonstrate that TET3 mediates increased 
hydroxymethylation at DSBs (Jiang et al, 2017). Notably, these studies provide no 
evidence for the recruitment of TET3 to DNA damage sites. In line with these 
observations, our results demonstrate that TET3 recruits to DNA damage sites. 
Meanwhile, new studies are emerging which highlight a non-catalytic role of TET3 
(Krueger et al, 2017; Montalban-Loro et al, 2019), Therefore, it is possible that this  
independent catalytic activity of TET3 may play a role in DDR response. More 
investigations are necessary to evaluate this idea. 
 
As all the TET proteins are shown to be involved in DDR, one of the questions that 
remain unanswered is whether, in the absence of TET3, TET1 and TET2 can 
compensate for the DNA repair. Previous studies have shown that TET1 and TET2 
facilitate NHEJ-mediated DDR response (Lu et al, 2016; Zhong et al, 2017), 
surprisingly which is quite opposite to our present findings on the role of TET3 in 
facilitating HR-mediated DNA repair response. Moreover, as in the present study we 
propose a non-catalytic role of TET3 in DNA repair, hence, it would be interesting to 
investigate whether the other isoforms can also participate in DNA repair response 
independent of their catalytic function. In line with this idea, a recent study in HEK293 
and MEFs demonstrate, a hydroxymethylation independent role of TET1 in NHEJ-
mediated DNA repair, by forming a chromatin associated complex with sin3a and 
hMOF transcriptional factors (Zhong et al, 2017). Therefore, further investigations are 
necessary to understand the in-depth mechanism on how specific TET isoforms and 
their distinct domains play a decisive role in DNA DSB repair response. 
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In the present study, we illustrate that TET3 is involved in HR-mediated DDR (Figure 
23). One of the crucial stages of HR is the resection of DNA around DSBs to expose 
ssDNA, which is necessary to orchestrate RAD51-mediated strand invasion (Huertas, 
2010). We observed that TET3 deficiency results in impairment of BrdU incorporation 
(Figure 24), which is a direct readout for ongoing DNA end resection (Mukherjee et 
al, 2015). Furthermore, we also observed improper loading of RAD51 at the γ-H2AX 
foci in TET3-deficient cardiac fibroblasts, strengthening our hypothesis about 
diminished DNA end resection. However, we do not observe any change in NHEJ 
repair efficiency or recruitment of NHEJ core proteins 53bp1 between TET3-deficient 
or control fibroblasts (Figure 23). Hence, it is highly likely that such an outcome can 
also result from a direct interaction of TET3 with RAD51 (mediating HR) but not with 
53bp1 (mediating NHEJ). 
 
 
4.2 TET3 may affect replication stress in cardiac fibroblasts 
 
In the present study, we demonstrate that the loss of TET3 in MCFs results in impaired 
recruitment of RAD51 to the DSB (Figure 25). Interestingly, studies have shown that 
impaired recruitment of RAD51 is also associated with replication stress (Ait Saada et 
al, 2018). Persistent replication stress can result in endogenous DNA DSBs. This 
potentially explains our observed results on the generation of DSBs upon TET3 
knockdown. Additionally, a pathway analysis using the string database surprisingly 
illustrates that most TET3 predicted interaction partners, apart from carbonic 
anhydrase2 and nanog, are associated with either proper maintenance or processing 
of the replicating fork (Figure 37) (Hervouet et al, 2018; Rehman et al, 2018; 
Rondinelli et al, 2017; Slenn et al, 2014). It is therefore highly likely, that TET3, apart 
from its role in DNA damage and repair, can also be involved in the proper 
maintenance and functioning of replicating forks in cells. 
 
As replicating origins are highly enriched in GC content (Cadoret et al, 2008), we 
hypothesize that TET3 can catalyze hydroxymethylation in these regions to mediate 
the maintenance of the replicating origins. This idea is supported by a recent study 
wherein TET2-mediated hydroxymethylation is reported to play a crucial role in the 
maintenance of replicating fork origins (Prikrylova et al, 2019). As most TET proteins 
are highly redundant in function, it is possible that, as per our hypothesis, TET3 can 
also be involved in replication stress and the maintenance of replicating fork origins. 
Further investigation could seek to answer whether TET3 is also involved in fine-
tuning the replication fork or may be involved in orchestrating the DNA replication 
origin firing.  
 
In line with these ideas, increased replication stress is a common feature in 
Doxorubicin-induced cardiac failure (Yang et al, 2014). Similarly, increased replication 
stress is also observed in cardiac failure due to mutations in laminin A/C genes 
(Graziano et al, 2018). Notably, so far in pathological cardiac diseases, the role and 
involvement of replication stress are not well known. In the present study, we report 
that TET3 expression is downregulated during cardiac fibrosis; therefore, further 
TET3 impacts cardiac fibrosis partially via regulation of DNA damage response  
   
  
Sandip Kumar Rath  2019  Page 73 
research can link the possible role of TET3 in fine-tuning the replication stress during 
cardiac fibrosis. 
 
            
            
 
Figure 37. Schematic representation of TET3 interaction partners analysed from the 
string database (Jensen et al, 2009). 
 
 
4.3 TET3 affects chromatin relaxation during DNA damage response in 
cardiac fibroblasts 
 
One of the key findings of the present study is that TET3 also plays a role in relaxing 
chromatin (Figure 27). This finding is in line with a recent report in the literature 
wherein the loss of TET3 is shown to facilitate heterochromatin formation via an 
increase in H3k27me3 (Cao et al, 2019). It is well known that unrelaxed chromatin can 
hinder the proper operation of DNA damage and repair response (Hauer & Gasser, 
2017). In line with these observations, our results also show impaired recruitment of 
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RAD51 to the DNA DSBs in TET3 knockdown MCFs. Thus, we hypothesize that 
changes in the chromatin landscape might affect the loading of RAD51 to the DNA 
DSBs in TET3-deficient cells. Studies also indicate that one of the essential 
prerequisites for proper HR-mediated DDR is the availability of relaxed chromatin 
architecture (Densham & Morris 2019). In a relaxed chromatin architecture, eviction 
of nucleosomes around the DSBs would facilitate smooth DNA end resection followed 
by strand invasion (Garvin et al, 2013). Our results are coherent with previously 
published findings, as we also observed that TET3 deficient cells with a compacted 
chromatin architecture show inefficient DNA end resection (Figure 24). However, it 
is unclear whether compacted chromatin in TET3-deficient cells is due to physiological 
tight nucleosome sliding or due to increased tail bridging of histones. More research is 
needed in this area. 
 
Existing studies have highlighted both catalytic domain dependent and independent 
roles of TET3. Thus, it is of interest in the future to investigate which domain of the 
TET3 aids in relaxing chromatin during DNA damage. Moreover, more investigations 
are necessary to determine whether chromatin compaction by loss of TET3 is the cause 
or consequence of the observed endogenous DNA DSBs. Interestingly, a recent study 
in mouse embryonic stem cells illustrates that exon number 4 of TET3 is present in the 
N-terminal domain (not in the catalytic domain), is highly conserved and helps in 
relaxing the chromatin (Krueger et al, 2017). In the same study, using only the exon 4 
overexpression studies, the authors displayed extensive relaxed chromatin by ATAC 
sequencing. Moreover, the authors also claimed that such a conserved region is absent 
in TET1 and TET2, suggesting that the chromatin relaxation is a unique feature of TET3 
among all the other isoforms. More investigations are also required to verify that the 
exon 4 of TET3 is critical in relaxing the chromatin in response to DNA DSBs. We also 
propose that generating the truncated versions of TET3 can help us to understand the 
precise role of each part of the domain in chromatin relaxation and DDR response.  
Interestingly, as previously discussed, the N-terminal domain of the protein is highly 
subject to post-translational modifications; therefore, it is likely that TET3 can play a 
role in DNA damage and repair response, independent of its catalytic domain due to 
its involvement in relaxing the chromatin. Apart from DDR, the extent of chromatin 
relaxation upon TET3 knockdown can also help us to understand the dynamics of 
chromatin looping and bending, which in turn tightly controls gene expression during 
fibrosis. Hence, for the future, we propose that a detailed Hi-C chromatin 
conformation capture analysis overlapped with an ATAC analysis in TET3 knockdown 
MCFs can aid in exploring the intricacy of chromatin loops and enhancer organization 
during fibrotic progression. 
 
 
4.4 TGF-β affects DNA repair and proliferation in cardiac fibroblasts 
 
In a physiological state, cardiac fibroblasts are more or less quiescent, but in 
pathological conditions, their proliferation is critical for fibrotic scarring. Interestingly, 
we have observed that fibrotic fibroblasts have an increased proliferation rate despite 
accumulating DNA damage (Figure 11). This led to the question: How do fibrotic 
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fibroblasts enter proliferation?  In order to provide an answer to this question, we 
contemplated two hypotheses: First, they may be adapting and tolerating DNA 
damage, or second, they could actually harness the fibrotic niche to accelerate DNA 
repair. Adaptation to DNA damage leads to genomic instability (GI) (Tubbs & 
Nussenzweig, 2017), but, to our knowledge, there are no reports of GI during cardiac 
fibrosis. Moreover, we also looked for abnormal anaphasic bridges (an indicator of GI) 
in murine fibrotic hearts, and no such abnormality was detected, at least in our sample 
size.  
 
Therefore, we focused on the second hypothesis that the fibrotic fibroblasts enter 
proliferation in a fibrotic niche due to a switch in DDR. To test this idea, we treated 
cardiac fibroblasts in vitro with TGF-β (a key molecule driving fibrotic progression). 
Our data show that MCFs treated with TGF-β tend to accelerate the clearance of DSBs 
by engaging increased NHEJ-mediated DDR response (Figure 29 and Figure 30). 
This is also coherent with the existing literature, where TGF-β is shown to accelerate 
clearance of the DSBs induced by ionizing radiation via NHEJ engagement in various 
cancer models (Kim et al, 2015).  
 
However, in the present study, we have not addressed whether the increase in NHEJ 
efficacy due to TGF-β treatment is due to increased 53bp1 expression or increased 
ligase 4 expression. Further experiments are needed to answer these questions. 
Moreover, TGF-β is primarily cytoplasmic by localization, and as per previous studies, 
most of its action in the nucleus is due to activated p-Smad2/3. It is of high interest to 
investigate whether activated p-Smad2/3 also plays a role in NHEJ DDR response in 
cardiac fibroblasts.  
 
Interestingly, our results also demonstrate that MCFs upon treatment with TGF-β 
show decreased TET3 expression. This is in line with previously published studies, 
wherein a similar effect of TGF-β was observed (Gong et al, 2017; Tampe et al, 2014; 
Xu et al, 2015; Ye et al, 2016; Zhang et al, 2014). So far, the exact mechanism that 
impairs TET3 expression has not been addressed in cardiac fibroblasts. In light of this 
observation, as the TET3 promoter consists of both smad binding sites as well as CpG 
islands, it would be interesting to address, if either of these axes together or 
independently regulate TET3 expression in MCFs. We propose bisulfite sequencing of 
TET3 promoter region along with ChIP studies on activated smad-3 binding to help 
resolve this question.  
 
 
4.5 TET3 affects DNA repair and proliferation in cardiac fibroblasts 
 
In the present study, we established that TET3 plays a role in HR in MCFs and TGF-β-
treatment downregulates TET3 expression (Figure 28).  Altogether, these results led 
us to hypothesize that decreased TET3 expression is a strategy employed by the fibrotic 
fibroblasts to evade activation of checkpoint arrest assisted HR-mediated repair 
response to promote increased cell proliferation. However, we also demonstrated that 
further knockdown of TET3 has no additive effect on the change in the cell proliferation 
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state in TGF-β-treated MCFs (Figure 31). But, interestingly, our results demonstrate 
that TET3 overexpression in TGF-β-treated MCFs also leads to shift in NHEJ repair 
efficacy (Figure 33). We propose, such result could be a consequence of increased 
DNA end resection in a relaxed chromatin. This idea is consistent with a recent study, 
wherein knockdown of CCAR2 is reported to decrease in the NHEJ repair efficacy due 
to an increase in HR-mediated DNA end resection (Lopez-Saavedra et al, 2016). 
Therefore, altogether from the results in the present study we can conclude that the 
anti-proliferative effect of TET3 in fibrotic fibroblasts is in part due to a shift in DNA 
repair. Hence, more investigations are necessary to understand whether the observed 
decreased cell proliferation upon TET3 overexpression is due to the altered chromatin 
architecture or DNA end resection or a consequence of both.   
 
 
5. Conclusion and Therapeutic Outlook 
 
Taking the patient data and in vitro and in vivo results in mouse hearts together, we 
demonstrated that fibrotic fibroblasts show a loss of TET3 expression. Moreover, using 
MCFs as in in vitro model, here, we demonstrate that TET3 additionally impacts DNA 
damage response (DDR) mechanisms via orchestrating checkpoint-assisted 
homologous recombination (HR)-mediated DDR, and that TGF-β, in combination 
with lack of TET3 in cardiac fibrosis, leads to an increase of a checkpoint-independent 
non-homologous end joining (NHEJ) DDR. In addition, from our in vitro results, we 
demonstrated that TET3 relaxes the chromatin which we propose may facilitate HR-
mediated DNA repair. Altogether from our results, we suggest a protective role of TET3 
in cardiac fibrosis. However, the in vivo landscape in heart is highly dynamic and 
regulated by cross-talks between different cell types. In line with these observations, 
there are still many unanswered questions concerning the findings of our results 
precisely in the in vivo situation. Hence, more investigations are necessary to address 
these answers using a TET3 knockout mouse challenged with fibrosis. 
 
From a therapeutic point of view, a previous study from our lab demonstrated a dose-
dependent anti-fibrotic effect of the anti-hypertensive drug hydralazine which 
upregulates TET3 expression (Tampe et al, 2015). Hence, it would be interesting to 
recapitulate these findings in fibrotic mouse hearts and look upon the protective role 
of TET3 during fibrosis in context of DNA repair. Hydralazine has a definite effect on 
other factors, too, but as it upregulates TET3 expression, it appears highly likely that it 
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